<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>IGCS 2008 - Poster Presentations</title> <link rel="stylesheet" href="../igcs-12.css" type="text/css"> </head> <body> <table width="742" border="0" align="center" cellpadding="0" cellspacing="0" bgcolor="#FFFFFF" style="border:1px solid #073D79; "> <tr> <td colspan="2" align="center" bgcolor="#242746"><table width="750" border="0" cellpadding="0" cellspacing="0" bgcolor="#00487F"> <tr> <td>&nbsp;</td> <td>&nbsp;</td> <td><img src="/igcs2008/images/envelope.gif" width="24" height="29" /></td> <td ><a href="javascript://;" onClick="window.open('https://www.kenes.com/mailing/IGCS-12/','_blank','height=500,width=650,top=50,left=10,status=yes,toolbar=no,menubar=no,location=no,scrollbars=yes')" style="color:white; font-size:10px;">KEEP ME UPDATED</a></td> <td>&nbsp;</td> <td><img src="/igcs2008/images/phone.gif" width="24" height="29" /></td> <td class="strip"><a href="javascript://;" onClick="window.open('https://www.kenes.com/tell-friend/IGCS-12/','_blank','height=500,width=650,top=50,left=10,status=yes,toolbar=no,menubar=no,location=no,scrollbars=yes')" style="color:white; font-size:10px;">TELL A FRIEND</a></td> <td>&nbsp;</td> <td><img src="/igcs2008/images/star.gif" width="24" height="29" /></td> <td class="strip"><a href="javascript:CreateBookmarkLink()" style="color:white; font-size:10px;">ADD TO MY FAVORITES</a></td> <td class="strip"><a href="http://www.igcs.org/membership/becomeMember.html" target="_blank"><img src="/igcs2008/images/info.gif" alt="become a member" width="51" height="29" border="0" /></a></td> <td width="208" align="right" class="strip"><img src="/igcs2008/images/top_r.jpg" width="208" height="29" /></td> </tr> </table> </td> </tr> <tr> <td colspan="2" align="center" bgcolor="#242746"><a href="http://www.kenes.com/igcs2008/"><img src="/igcs2008/images/tittle2.jpg" alt="IGCS 2008 - 12th Biennial Meeting, International Gynecologic Cancer Society, Bangkok, Thailand, October 25-28, 2008 " width="750" height="170" border="0" /></a></td> </tr> <tr> <td width="152" class="leftmenu"><ul id="left_menu"> <li><a href="/igcs2008/">Home</a></li> <li><a href="/igcs2008/welcome.asp">Welcome Letters</a></li> <li><a href="/igcs2008/committees.asp">Committees</a></li> <li><a href="http://81.209.169.154/igcs2008/psIPlanner.aspx" target="_blank">Scientific Program</a></li> <li><a href="/igcs2008/satellite.asp">Satellite Symposium</a></li> <li><a href="/igcs2008/program_highlights.asp">Program Highlights</a></li> <li><a href="/igcs2008/call_late.asp">Call for Abstracts</a></li> <li><a href="/igcs2008/abstract_topics.asp">Abstract Topics</a></li> <li><a href="/igcs2008/information.asp">Information for Oral & Poster Presenters</a></li> <li><a href="/igcs2008/general_information.asp">General Information</a></li> <li><a href="/igcs2008/Registration.asp">Registration</a></li> <li><a href="/igcs2008/Accommodation.asp">Hotel Accommodation</a></li> <li><a href="/igcs2008/meet_the_professor.asp">Meet the Professor Sessions</a></li> <li><a href="/igcs2008/Accompanying_Person_Program.asp" >Accompanying Person's Program</a></li> <li><a href="/igcs2008/events.asp">Social Events</a></li> <li><a href="/igcs2008/meeting.asp">Pre-and Post-Meeting</a></li> <li><a href="/igcs2008/about.asp">About Bangkok</a></li> <li><a href="/igcs2008/sponsors.asp">Sponsors</a></li> <li><a href="/igcs2008/sponsorship.asp">Sponsorship & Exhibition</a></li> <li><a href="/igcs2008/invitation_letter.asp">Invitation Letter</a></li> <li><a href="/igcs2008/Italian_agent.asp">Official Italian Agent for Italian Participants</a></li> <li><a href="/igcs2008/official_carrier.asp" >Official Airline Carrier</a></li> <li><a href="http://www.kenes.com/igcs-11/" target="_blank">Previous Meeting</a></li> <li><a href="/igcs2008/contact.asp">Contact Us</a></li> </ul></td> <td width="588" valign="top" id="content"><h1>Poster Presentations</h1> <br> <P><b><u>Saturday, October 25, 2008</u></b></P><H2>Poster Session 1: Category A: CERVICAL CANCER</H2><p> <b>85</b><br> <a href='PDF/8.pdf' target='_blank'><b>THE RESULTS OF CERVICAL CONE EXCISION BIOPSY</b></a><br> <b>M. Karimi Zarchi</b><sup>1</sup>, F. Ghaemmaghami<sup>2</sup>, A. Mousavi<sup>3</sup>, Z. Ale-Mohammad<sup>2</sup><br> <em><sup>1</sup>Shahid Sadoughi University, Gynecologic Oncology, Yazd, Iran, Islamic Republic of, <sup>2</sup>Tehran University of Medical Science, Tehran, Iran, Islamic Republic of, <sup>3</sup>Tehran University of Medical Science, Gynecologic Oncology, Tehran, Iran, Islamic Republic of</em><br> </p> <p> <b>86</b><br> <a href='PDF/13.pdf' target='_blank'><b>HPV DNA IN THE TISSUE OF CERVICAL CARCINOMA, IN SENTINEL AND PELVIC LYMPH NODES - CORRELATION WITH HISTOPATHOLOGICAL FINDINGS</b></a><br> <b>J. Slama</b><sup>1</sup>, D. Cibula<sup>1</sup>, M. Drazdakova<sup>2</sup>, P. Dundr<sup>3</sup>, D. Fischerova<sup>1</sup>, M. Zikan<sup>1</sup>, P. Freitag<sup>1</sup>, I. Pinkavova<sup>1</sup>, J. Svarovsky<sup>1</sup><br> <em><sup>1</sup>General Teaching Hospital and 1st Faculty of Medicine, Charles University, Department of Oncogynecology, Prague, Czech Republic, <sup>2</sup>General Teaching Hospital and 1st Faculty of Medicine, Charles University, Department of Microbiology and Molecular Biology, Prague, Czech Republic, <sup>3</sup>General Teaching Hospital and 1st Faculty of Medicine, Charles University, Department of Pathology, Prague, Czech Republic</em><br> </p> <p> <b>87</b><br> <a href='PDF/24.pdf' target='_blank'><b>CERVICAL CANCER CHARACTERISTICS AFTER THE INTRODUCTION OF A NATIONAL CANCER SCREENING PROGRAM IN SLOVENIA</b></a><br> <b>I. Taka </b><sup>1</sup>, M. Urai -Vra aj<sup>2</sup>, A. Repae-Fokter<sup>3</sup>, T. Kodri <sup>4</sup>, S. Rakar<sup>5</sup>, A. Mo~ina<sup>5</sup>, S. Smrkolj<sup>5</sup>, M. Primic-}akelj<sup>6</sup>, V. Str~inar<sup>2</sup>, A. Vakselj<sup>2</sup>, D. Bosilj<sup>4</sup>, M. ebulj<sup>4</sup>, B. Goriaek<sup>4</sup>, M. Mar ec<sup>4</sup>, D. Ognjenovik<sup>4</sup>, D. Arko<sup>4</sup><br> <em><sup>1</sup>Maribor University Hospital, University Department of Gynecology and Perinatology, Maribor, Slovenia, <sup>2</sup>Institute of Oncology, Ljubljana, Slovenia, <sup>3</sup>General Hospital Celje, Department of Pathology, Celje, Slovenia, <sup>4</sup>Maribor University Hospital, Department of Gynecologic Oncology and Oncology of the Breasts, Maribor, Slovenia, <sup>5</sup>University Medical Center, Department of Gynecology and Obstetrics, Ljubljana, Slovenia, <sup>6</sup>Cancer Registry of Slovenia, Ljubljana, Slovenia</em><br> </p> <p> <b>88</b><br> <a href='PDF/33.pdf' target='_blank'><b>HIPK2, HPV AND APOPTOSIS IN CERVICAL CANCER</b></a><br> <b>M. Al-Beiti</b>, X. Lu, X. Liu<br> <em>The Obstetrics and Gynecology Hospital of Fudan University, Department of Gynecology, Shanghai, China</em><br> </p> <p> <b>89</b><br> <a href='PDF/37.pdf' target='_blank'><b>ASSOCIATION BETWEEN THE COMMON METHODS OF CONTRACEPTIVES USE AND INVASIVE CERVICAL </b><b>CARCINOMA</b></a><br> <b>S. Azima</b><br> <em>Shiraz University of Medical Sciences, College of Nursing and Midwifery, Shiraz, Iran, Islamic Republic of</em><br> </p> <p> <b>90</b><br> <a href='PDF/56.pdf' target='_blank'><b>HPV PREVALENCE IN WOMEN WITH INVASIVE CERVICAL CANCER OR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA IN MALAYSIA: PRELIMINARY RESULTS</b></a><br> <b>B.-K. Lim</b><sup>1</sup>, R. Soon<sup>2</sup>, J. Chen<sup>3</sup>, N.A. Mat Adenan<sup>1</sup>, N. Sabir<sup>1</sup>, C.-M. Yong<sup>2</sup>, S. Subramaniam<sup>2</sup>, P.L. Cheah<sup>4</sup>, T.L. Ng<sup>3</sup>, Y.-L. Teoh<sup>3</sup>, H.L. Bock<sup>3</sup><br> <em><sup>1</sup>University of Malaya, Department of Obstetrics and Gynecology, Kuala Lumpur, Malaysia, <sup>2</sup>Hospital Likas, Department of Obstetrics and Gynecology, Kota Kinabalu, Malaysia, <sup>3</sup>GlaxoSmithKline Biologicals, Rixensart, Belgium, <sup>4</sup>University of Malaya, Department of Pathology, Kuala Lumpur, Malaysia</em><br> </p> <p> <b>91</b><br> <a href='PDF/86.pdf' target='_blank'><b>COMPARING VIA AND PAP SMEAR RESULT IN CERVICAL CANCER SCREENING A PRELIMINARY STUDY AT KATH, KUMASI GHANA</b></a><br> <b>B. Awuah</b><br> <em>Komfo Anokye Teaching Hospital, Oncology, Kumasi, Ghana</em><br> </p> <p> <b>92</b><br> <a href='PDF/89.pdf' target='_blank'><b>CHEMORADIATION OF CERVICAL CANCER WITH WEEKY GEMCITABINE AND CISPLATIN (CG) IN COMPARISON WITH CISPLATIN (C) ;GORGANI 1 TRIAL (ISRCTN29976507)</b></a><br> <b>A. Ameri</b><sup>1</sup>, R. Khandoozi<sup>1</sup>, K.M. Sheibani<sup>1</sup>, A. Alidoosti<sup>1</sup>, N. Behtash<sup>2</sup>, A. Moosavi<sup>2</sup><br> <em><sup>1</sup>Imam Hossein Hospital Shahid Beheshti University MC, Radiation Oncology, Tehran, Iran, Islamic Republic of, <sup>2</sup>Imam Khomeini Hospital Tehran University of Medical Science, Gynecology Oncology, Tehran, Iran, Islamic Republic of</em><br> </p> <p> <b>93</b><br> <a href='PDF/100.pdf' target='_blank'><b>DOES EPSTEIN-BARR VIRUS</b><b> PLAY A ROLE IN LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE UTERINE CERVIX? </b></a><br> <b>A. Chao</b>, S. Hsueh, S.-L. Huang, F.-Y. Chao, C.-H. Lai<br> <em>Chang Gung Memorial Hosp, Kueishan, Taoyuan, Taiwan, Republic of China</em><br> </p> <p> <b>94</b><br> <a href='PDF/107.pdf' target='_blank'><b>PHASE II STUDY OF RADIATION THERAPY COMBINED WITH WEEKLY NEDAPLATIN IN LOCALLY ADVANCED UTERINE CERVICAL CARCINOMA: KGROG0501 - INITIAL ANALYSIS </b></a><br> <b>Y. Niibe</b><sup>1</sup>, S. Tsunoda<sup>2</sup>, M. Arai<sup>2</sup>, T. Arai<sup>2</sup>, M. Kawaguchi<sup>2</sup>, M. Kuzuoka<sup>2</sup>, S. Ono<sup>2</sup>, K. Matsunaga<sup>1</sup>, Y. Hamada<sup>3</sup>, K. Matsuo<sup>4</sup>, T. Jobo<sup>2</sup>, N. Unno<sup>2</sup>, K. Hayakawa<sup>1</sup><br> <em><sup>1</sup>Kitasato University School of Medicine, Department of Radiology, Sagamihara, Japan, <sup>2</sup>Kitasato University School of Medicine, Department of Obsterics and Gynecology, Sagamihara, Japan, <sup>3</sup>Kitasato University Hospital, Division of Clinical Pharmacology, Sagamihara, Japan, <sup>4</sup>Aichi Cancer Center, Division of Epidemiology and Prevention, Nagoya, Japan</em><br> </p> <p> <b>95</b><br> <a href='PDF/111.pdf' target='_blank'><b>VALIDITY AND PREDICTIVE VALUES OF SCREENING TESTS USED TO DETECT PRE-CANCEROUS AND CANCEROUS LESIONS OF UTERINE CERVIX</b></a><br> <b>A. Kangolle</b><sup>1</sup>, D.R. Lyimu<sup>2</sup><br> <em><sup>1</sup>Ocean Road Cancer Institute, Epidemiology and Biostatistics, Dar es Salaam, Tanzania, United Republic of, <sup>2</sup>Ocean Road Cancer Institute, Clinical Services, Dar es Salaam, Tanzania, United Republic of</em><br> </p> <p> <b>96</b><br> <a href='PDF/115.pdf' target='_blank'><b>SCREENING FOR CERVICAL CANCER IN LOW RESOURCE SETTINGS - EVALUATION OF VISUAL INSPECTION WITH ACETIC ACID UNDER MAGNIFICATION (VIAM)</b></a><br> <b>P. Aggarwal</b>, S. Batra, G. Gandhi, V. Zutshi<br> <em>Maulana Azad Medical College & Lok Nayak Hospital, Department of Obstetrics & Gynecology, New Delhi, India</em><br> </p> <p> <b>97</b><br> <a href='PDF/126.pdf' target='_blank'><b>CLINICAL REPORT OF HIGH DOSE RATE (HDR) BRACHYTHERAPY BOOST USING INVERSE PLANNING SIMULATED ANNEALING (IPSA) FOR LOCOREGIONALLY ADVANCED CERVICAL CANCER</b></a><br> D. Kim<sup>1</sup>, A. Wang-Chesebro<sup>1</sup>, V. Weinberg<sup>1</sup>, J. Pouliot<sup>1</sup>, L.-M. Chen<sup>1</sup>, J. Speight<sup>1</sup>, R. Littell<sup>2</sup>, <b>I.-C. Hsu</b><sup>1</sup><br> <em><sup>1</sup>University of California, San Francisco (UCSF), San Francisco, United States, <sup>2</sup>Kaiser Permanente Medical Center, San Francisco, United States</em><br> </p> <p> <b>98</b><br> <a href='PDF/127.pdf' target='_blank'><b>CONCURRENT CHEMORADIOTHERAPY USING HIGH-DOSE RATE INTRACAVITARY BRACHYTHERAPY FOR LOCOREGIONALLY ADVANCED UTERINE CERVICAL CANCER</b></a><br> <b>T. Toita</b><sup>1</sup>, Y. Nagai<sup>2</sup>, W. Tamaki<sup>1</sup>, T. Ariga<sup>1</sup>, G. Kasuya<sup>1</sup>, K. Ogawa<sup>1</sup>, Y. Kakinohana<sup>1</sup>, M. Hirakawa<sup>2</sup>, M. Inamine<sup>2</sup>, C. Yagi<sup>2</sup>, Y. Aoki<sup>2</sup>, S. Murayama<sup>1</sup><br> <em><sup>1</sup>University of the Ryukyus, Graduate School of Medical Science, Radiology, Okinawa, Japan, <sup>2</sup>University of the Ryukyus, Graduate School of Medical Science, Obstetrics and Gynecology, Okinawa, Japan</em><br> </p> <p> <b>99</b><br> <a href='PDF/130.pdf' target='_blank'><b>RADICAL ABDOMINAL TRACHELECTOMY IN SECOND TRIMESTER OF PREGNANCY IN YOUNG PATIENT WITH CERVICAL CANCER - A CASE REPORT</b></a><br> <b>P. Novakovic</b><sup>1</sup>, A. Mandic<sup>1</sup>, D. Zikic<sup>1</sup>, O. Mihajlovic<sup>1</sup>, S. Milosevic<sup>2</sup>, D. Nincic<sup>1</sup>, J. Rajovic<sup>1</sup>, M. Zivaljevic<sup>1</sup><br> <em><sup>1</sup>Institute of Oncology Vojvodina, Sremska Kamenica, Serbia, <sup>2</sup>Clinical Center Vojvodina, Novi Sad, Serbia</em><br> </p> <p> <b>100</b><br> <a href='PDF/141.pdf' target='_blank'><b>PAP SMEAR</b></a><br> <b>F. Almassi Nokiani</b>, H. Akbari<br> <em>Medical Sciences University of Kermanshah, Gynecology, Tehran, Iran, Islamic Republic of</em><br> </p> <p> <b>101</b><br> <a href='PDF/148.pdf' target='_blank'><b>CLEARANCE OF HIGH RISK HUMAN PAPILLOMAVIRUS (HPV) DNA AND RESPONSE TO THERAPY</b></a><br> <b>B. Askandar</b><sup>1</sup>, A. Andrijono<sup>2</sup>, P. Hartono<sup>1</sup><br> <em><sup>1</sup>Dr. Soetomo Teaching Hospital/Airlangga University School of Medicine, Division of Gynecologic Oncology / Dept of Obstetrics and Gynecology, Surabaya, Indonesia, <sup>2</sup>Dr. Cipto Mangunkusumo Teaching Hospital/ Indonesian University School of Medicine, Division of Gynecologic Oncology / Dept of Obstetrics and Gynecology, Jakarta, Indonesia</em><br> </p> <p> <b>102</b><br> <a href='PDF/154.pdf' target='_blank'><b>SCREENING FOR CERVICAL CANCER USING PRIMARY HUMAN PAPILLOMAVIRUS (HPV) TESTING AND REFLEX CYTOLOGY: A COST EFFECTIVE ANALYSIS</b></a><br> <b>S. Schuman</b>, L. Barbee, M. Pearson, K. Nishida, J. Lucci III<br> <em>University of Miami-Miller School of Medicine, Gynecologic Oncology, Miami, United States</em><br> </p> <p> <b>103</b><br> <a href='PDF/184.pdf' target='_blank'><b>THE DISCOVERY OF ZII AS A POTENTIAL CANDIDATE FOR THE TREATMENT OF CERVICAL CANCER</b></a><br> <b>A. Abdul</b><sup>1</sup>, S. Ibrahim<sup>2</sup>, A. Al-Zubairi<sup>3</sup>, M. Syam<sup>3</sup><br> <em><sup>1</sup>University Putra Malaysia, Cancer Research Laboratory, Serdang, Malaysia, <sup>2</sup>UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, UPM, Serdang, Malaysia, <sup>3</sup>UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Serdang, Malaysia</em><br> </p> <p> <b>104</b><br> <a href='PDF/187.pdf' target='_blank'><b>STUDY ON THE EXPRESSION OF MICRORNA IN CERVICAL CANCER </b></a><br> Y. Lu, <b>K. Shen</b>, J.-X. Yang, M. Wu, J. Lang<br> <em>Peking Union Medical College Hospital, Obstetrics and Gynecology, Beijing, China</em><br> </p> <p> <b>105</b><br> <a href='PDF/204.pdf' target='_blank'><b>SCREENING FOR CERVICAL CANCER AMONG ISRAELI LESBIAN WOMEN</b></a><br> <b>M. Ben Natan</b><sup>1</sup>, O. Adir<sup>2</sup><br> <em><sup>1</sup>Pat Mattews Academic School of Nursing, Hadera, Israel, <sup>2</sup>Emergency Department Tel Aviv Sourasky Medical Center, Tel Aviv, Israel</em><br> </p> <p> <b>106</b><br> <a href='PDF/242.pdf' target='_blank'><b>HPV DNA IN LYPMH NODES OF PATIENTS WITH CERVICAL CANCER</b></a><br> <b>A. Peedicayil</b><sup>1</sup>, N. Sathish<sup>2</sup>, M. Gnanamony<sup>2</sup>, S. John<sup>3</sup>, S. Kurian<sup>4</sup>, F. Viswanathan<sup>3</sup>, P. Abraham<sup>2</sup><br> <em><sup>1</sup>Christian Medical College, Obstetrics & Gynaecology, Vellore, India, <sup>2</sup>Christian Medical College, Virology, Vellore, India, <sup>3</sup>Christian Medical College, Radiation Oncology, Vellore, India, <sup>4</sup>Christian Medical College, Pathology, Vellore, India</em><br> </p> <p> <b>107</b><br> <a href='PDF/245.pdf' target='_blank'><b>PREVALENCE OF HUMAN PAPILLOMA VIRUS, CHLAMYDIA TRACHOMATIS, AND TRICHOMONAS VAGINALIS IN CERVICAL INTRAEPITHELIAL NEOPLASIA - STUDY IN A TERTIARY CARE CENTRE</b></a><br> <b>H.P. Gupta</b><sup>1</sup>, A.N. Srivastava<sup>2</sup>, U. Singh<sup>1</sup><br> <em><sup>1</sup>C.S.M. Medical University, Obstetrics & Gynaecology, Lucknow, India, <sup>2</sup>C.S.M.Medical University, Pathology, Lucknow, India</em><br> </p> <p> <b>108</b><br> <a href='PDF/249.pdf' target='_blank'><b>CTLA4 +49A/G POLYMORPHISMS AND SUSCEPTIBILITY TO CERVICAL CANCER IN A CHINESE POPULATION</b></a><br> H. Guo<sup>1</sup>, <b>H. Li</b><sup>1</sup>, D. Lin<sup>2</sup>, M. Yang<sup>2</sup><br> <em><sup>1</sup>Third Hospital, Peking University, Department of Obstetrics and Gynecology, Beijing, China, <sup>2</sup>Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China</em><br> </p> <p> <b>109</b><br> <a href='PDF/261.pdf' target='_blank'><b>A RETROSPECTIVE EVALUATION OF OPERATION SITUATIONS AND LONG-TERM OUTCOMES IN 440 PATIENTS WITH INVASIVE CERVICAL CANCER</b></a><br> <b>X. Lu</b>, X. Liu, J. Gao<br> <em>Fudan University, Ob/Gyn Hospital, Shanghai, China</em><br> </p> <p> <b>110</b><br> <a href='PDF/265.pdf' target='_blank'><b>HYDRONEPHROSIS AFTER RADICAL HYSTERECTOMY: A PROSPECTIVE STUDY </b></a><br> <b>P. Suprasert</b><sup>1</sup>, P. Suriyachai<sup>1</sup>, J. Euathrongchit<sup>2</sup>, J. Srisomboon<sup>1</sup>, K. Charoenkwan<sup>1</sup>, C. Kietpeerakool<sup>1</sup>, C. Cheewakriangkrai<sup>1</sup>, S. Siriaree<sup>1</sup>, C. Saeteng<sup>1</sup>, C. Phongnarisorn<sup>1</sup><br> <em><sup>1</sup>Chiang Mai University, OB&GYN, Chiang Mai, Thailand, <sup>2</sup>Chiang Mai University, Radiology, Chiang Mai, Thailand</em><br> </p> <p> <b>111</b><br> <a href='PDF/294.pdf' target='_blank'><b>ROLEOF INTERSTITIAL BRACHYTHERAPY USING MUPIT IN LOCALLY ADVANCED GYNECOLOGICALMALIGNANCIES</b></a><br> <b>R.K. Vyas</b>, U.K. Suryanarayan, C.L. Amin, P.N. Patel<br> <em>Gujarat Cancer & Research Institute, Department of Radiation Oncology, Ahmedabad, India</em><br> </p> <p> <b>112</b><br> <a href='PDF/312.pdf' target='_blank'><b>RADICAL HYSTERECTOMY FOLLOWING INTENSITY MODULATED ARC THERAPY (IMAT) IN THE MULTIMODALITY TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER</b></a><br> <b>A.P. Makar</b><sup>1</sup>, K. Vandecasteele<sup>2</sup>, G. Villeirs<sup>3</sup>, H. Denys<sup>4</sup>, R. Van den Broecke<sup>1</sup>, V. Cocquyt<sup>4</sup>, K. Lambein<sup>5</sup>, V. Fonteyne<sup>2</sup>, L. Delrue<sup>3</sup>, P. Tummers<sup>1</sup>, G. De Meerleer<sup>2</sup><br> <em><sup>1</sup>University Hospital of Ghent, Department of Gynecologic Oncology, Ghent, Belgium, <sup>2</sup>University Hospital of Ghent, Department of Radiotherapy, Ghent, Belgium, <sup>3</sup>University Hospital of Ghent, Department of Radiology, Ghent, Belgium, <sup>4</sup>University Hospital of Ghent, Department of Medical Oncology, Ghent, Belgium, <sup>5</sup>University Hospital of Ghent, Department of Pathology, Ghent, Belgium</em><br> </p> <p> <b>113</b><br> <a href='PDF/314.pdf' target='_blank'><b>POST TREATMENT CIN: RANDOMISED CLINICAL TRIAL USING HRHPV-TESTING FOR PREDICTION OF RESIDUAL/RECURRENT DISEASE</b></a><br> <b>A. Bais</b><sup>1</sup>, M. Eijkemans<sup>2</sup>, M. Rebolj<sup>2</sup>, P. Snijders<sup>3</sup>, R. Verheijen<sup>4</sup>, M. van Ballegooijen<sup>2</sup>, C. Meijer<sup>3</sup>, T. Helmerhorst<sup>1</sup><br> <em><sup>1</sup>Erasmus University Medical Center, Gynaecology, Rotterdam, Netherlands, <sup>2</sup>Erasmus University Medical Center, Public Health, Rotterdam, Netherlands, <sup>3</sup>VU University Medical Center, Pathology, Amsterdam, Netherlands, <sup>4</sup>VU University Medical Center, Gynaecology, Amsterdam, Netherlands</em><br> </p> <p> <b>114</b><br> <a href='PDF/331.pdf' target='_blank'><b>RADICAL HYSTERECTOMY IN RESIDUAL AND RECURRENT CERVICAL CANCER FOLLOWING RADIATION THERAPY: MNJIO&RCC, INDIA EXPERIENCE</b></a><br> <b>U.R. Poli</b><sup>1</sup>, R. Maturi<sup>1</sup>, S.R. Tamminedu<sup>2</sup><br> <em><sup>1</sup>MNJ Institute of Oncology & Regional Cancer Center, Surgical Oncology, Hyderabad, India, <sup>2</sup>MNJ Institute of Oncology & Regional Cancer Center, Hyderabad, India</em><br> </p> <p> <b>115</b><br> <a href='PDF/343.pdf' target='_blank'><b>COMPARE OF THREE METHODS BASED ON POLYMERASE CHAIN REACTION FOR DETECTION OF HUMAN PAPILLOMAVIRUS AND SCREENING OF CERVICAL LESION</b></a><br> <b>Q. Chen</b><sup>1</sup>, M. Bian<sup>1</sup>, H. Xu<sup>2</sup>, X. Zhang<sup>3</sup>, P. Tao<sup>4</sup>, H. Ou<sup>1</sup><br> <em><sup>1</sup>China-Japan Friendship Hospital, Obstetrics and Gynecology, Beijing, China, <sup>2</sup>Shaoxing Maternity and Child Health Hospital, Obstetrics and Gynecology, Shaoxing, China, <sup>3</sup>Haidian Maternal and Child Health Hospital, Obstetrics and Gynecology, Beijing, China, <sup>4</sup>Shaoxing People's Hospital, Obstetrics and Gynecology, Shaoxing, China</em><br> </p> <p> <b>116</b><br> <a href='PDF/397.pdf' target='_blank'><b>PROGNOSTIC SIGNIFICANCE OF SERUM VEGF-C AND LVSI IN EARLY STAGE CERVICAL CANCER</b></a><br> <b>H. Priyanto</b><sup>1</sup>, A. Andrijono<sup>2</sup><br> <em><sup>1</sup>Dr. Moewardi General Hospital - Sebelas Maret University, Oncology Division, Obstetrics and Gynecology Department, Solo Centre Java, Indonesia, <sup>2</sup>Dr. Cipto Mangunkusumo General Hospital University of Indonesia, Oncology Division Obstetric and Gynecology Department, Jakarta, Indonesia</em><br> </p> <p> <b>117</b><br> <a href='PDF/401.pdf' target='_blank'><b>DISTRIBUTION OF HUMAN PAPILLOMAVIRUS GENOTYPES IN INVASIVE CERVICAL CANCER IN ITALY: A REPRESENTATIVE, SINGLE INSTITUTION CASE SERIES OF 268 CASES</b></a><br> <b>M. Sideri</b><sup>1</sup>, S. Igidbashian<sup>1</sup>, S. Boveri<sup>1</sup>, C. Casadio<sup>2</sup>, P. Cristoforoni<sup>1</sup>, M. Schmitt<sup>3</sup>, T. Gheit<sup>4</sup>, M. Tommasino<sup>4</sup><br> <em><sup>1</sup>European Insitute of Oncology, Gynecology, Milano, Italy, <sup>2</sup>European Institute of Oncology, Pathology, Milano, Italy, <sup>3</sup>German Cancer Research Center, Infection and Cancer, Heidelberg, Germany, <sup>4</sup>International Agency for Research on Cancer, Infection and Cancer, Lyon, France</em><br> </p> <p> <b>118</b><br> <a href='PDF/413.pdf' target='_blank'><b>CORRELATION BETWEEN HISTOLOGICAL REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND HUMAN PAPILLOMAVIRUS CLEARANCE</b></a><br> <b>Y.L. Woo</b><sup>1</sup>, J.C. Sterling<sup>2</sup>, S.H. van der Burg<sup>3</sup>, M.A. Stanley<sup>2</sup>, R.A.F. Crawford<sup>4</sup><br> <em><sup>1</sup>Department of Pathology, University of Cambridge, Department of Gynaecological Oncology, Addenbrook's Hospital, Cambridge, United Kingdom, <sup>2</sup>University of Cambridge, Department of Pathology, Cambridge, United Kingdom, <sup>3</sup>Leiden University Medical Centre, Deparment of Clinical Oncology, Leiden, Netherlands, <sup>4</sup>Addenbrooke's Hospital, Department of Gynaecological Oncology, Cambridge, United Kingdom</em><br> </p> <p> <b>119</b><br> <a href='PDF/417.pdf' target='_blank'><b>STUDY ON THE RELATIONSHIP BETWEEN PARAMETRIAL INFILTRATION, LVSI,STAGING, PROGNOSIS AND OTHER HISTOPATOLOGIC PARAMETERS OF SQUAMOUS CERVICAL CANCER IN CHINESE WOMEN</b></a><br> <b>M.R. Xi</b>, Z.Y. Cao, H. Liu, H.G. Wang, A. Zheng, Z.L. Peng, Q. Chai, X.L. Wan<br> <em>The University Hospital, Sichuan University, Dept. of Obs./Gynec, Chengdu, Sichuan, China</em><br> </p> <p> <b>120</b><br> <a href='PDF/418.pdf' target='_blank'><b>ANALYSIS ON THE ASSOCIATION BETWEEN CLINIC STAGING, LNM AND OTHER FACTORS IN 508 CERVICAL CACER PATIENTS IN SICHUAN PROVINCE</b></a><br> <b>M.R. Xi</b>, H.J. Wang, J. Zhang, Y. Cheng, M.M. Hou, A. Zheng, Z.L. Peng, Z.Y. Cao, X.L. Wan, Q. Chai<br> <em>The University Hospital, Sichuan University, Dept. of Obs./Gynec, Chengdu, Sichuan, China</em><br> </p> <p> <b>121</b><br> <a href='PDF/433.pdf' target='_blank'><b>ROUTINE USE OF INTRAOPERATIVE ULTRASOUND GUIDANCE DURING INTRACAVITARY TANDEM PLACEMENT FOR CANCER OF THE CERVIX</b></a><br> <b>R. Kim</b>, J. De Los Santos, S. Spencer<br> <em>University of Alabama at Birmingham, Radiation Oncology, Birmingham, United States</em><br> </p> <p> <b>122</b><br> <a href='PDF/458.pdf' target='_blank'><b>A HOSPITAL-BASED STUDY OF THE KNOWLEDGE AND ATTITUDE OF MOTHERS OF ADOLESCENTS REGARDING HPV INFECTION AND ITS POTENTIAL VACCINE</b></a><br> C.R. Zalameda-Castro, <b>E.J. Domingo</b><br> <em>University of the Philippines - Philippine General Hospital, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Manila, Philippines</em><br> </p> <p> <b>123</b><br> <a href='PDF/485.pdf' target='_blank'><b>LOUPES ASSISTED NERVE SPARING ABDOMINAL RADICAL TRACHELECTOMY, FOR EARLY-STAGE CERVICAL CANCER: TO REDUCE MORBIDITY AND IMPROVE OUTCOME</b></a><br> <b>A. Rodolakis</b>, Z. Voulgaris, G. Vlachos, D. Haidopoulos, N. Thomakos, A. Antsaklis<br> <em>Alexandra Hospital, 1st Dpt of Obstetrics & Gynaecology, Athens University Greece, Athens, Greece</em><br> </p> <p> <b>124</b><br> <a href='PDF/487.pdf' target='_blank'><b>MODIFIED ULTRA FAST PAPANICOULAOU STAINING - IS IT SUPERIOR TO THE CONVENTIONAL PAP STAINING IN DETECTION OF UTERINE CERVICAL NEOPLASIA?</b></a><br> <b>U. Singh</b><sup>1</sup>, A.N. Shrivastav<sup>2</sup>, J.S. Misra<sup>3</sup>, N. Singh<sup>1</sup>, P. Shankhwar<sup>1</sup><br> <em><sup>1</sup>C.S.M.Medical University, Obstetrics and Gynaecology, Lucknow, India, <sup>2</sup>C.S.M.Medical University, Pathology, Lucknow, India, <sup>3</sup>C.S.M.Medical University, Lucknow, India</em><br> </p> <p> <b>125</b><br> <a href='PDF/516.pdf' target='_blank'><b>CONCURRENT CHEMORADIOTHERAPY FOR</b> <b>LOCALLY ADVANCED CERVICAL CANCER:</b> <b>PRELIMINARY RESULTS OF TOXICITIES AND RESPONSE</b> <b>IN HO CHI MINH CITY ONCOLOGY HOSPITAL</b></a><br> <b>D.N.L. Tran</b><sup>1</sup>, A.K. Nguyen<sup>1</sup>, T.T.A. Cung<sup>1</sup>, H.Q.T. Dang<sup>1</sup>, H.M. Le<sup>1</sup>, C.H. Nguyen<sup>2</sup><br> <em><sup>1</sup>Ho Chi Minh City Oncology Hospital, Radiation Department, Ho Chi Minh City, Viet Nam, <sup>2</sup>Ho Chi Minh City University of Medicine and Pharmacy, Oncology Department, Ho Chi Minh City, Viet Nam</em><br> </p> <p> <b>126</b><br> <a href='PDF/553.pdf' target='_blank'><b>PERSISTENCE OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION IN A COHORT OF DANISH WOMEN </b></a><br> <b>A. Nielsen</b><sup>1</sup>, S. Krüger Kjær<sup>2</sup>, C. Munk<sup>1</sup>, M. Osler<sup>3</sup>, T. Iftner<sup>4</sup><br> <em><sup>1</sup>Institute of Cancer Epidemiology, Danish Cancer Society, Department of Viruses, Hormones and Cancer, Copenhagen, Denmark, <sup>2</sup>Institute of Cancer Epidemiology, Danish Cancer Society, Department of Viruses, Hormones and Cancer, Department of Gynecology and Obstetrics, Rigshopitalet, Copenhagen, Denmark, <sup>3</sup>Faculty of Health Science, University of Copenhagen, Institute of Public Health, Copenhagen, Denmark, <sup>4</sup>University Hospital of Tübingen, Department of Medical Virology, Tübingen, Germany</em><br> </p> <p> <b>127</b><br> <a href='PDF/577.pdf' target='_blank'><b>CYP1A1</b><b> AND </b><b>CYP2D6 </b><b>GENES POLYMORPHISM </b><b>IN ISRAELI JEWISH CERVICAL CANCER PATIENTS AND HEALTHY WOMEN</b></a><br> <b>G. Gutman</b>, B. Peleg, C. Peretz, A. Reches, B. Amiram, E. Rimon, J.B. Lessing, D. Grisaru<br> <em>Lis Maternity Hospital, Tel-Aviv, Israel</em><br> </p> <p> <b>128</b><br> <a href='PDF/594.pdf' target='_blank'><b>DIFFERENT TRENDING OF CERVICAL CANCER IN OLDER AND YOUNGER WOMEN</b></a><br> <b>H.-Y. Lau</b>, K.-C. Chao, Y.-J. Chen, N.-F. Twu, M.-S. Yen<br> <em>Taipei Veterans General Hospital, Department of Obstetrics and Gynecology, Taipei, Taiwan, Republic of China</em><br> </p> <p> <b>129</b><br> <a href='PDF/612.pdf' target='_blank'><b>THE EXPRESSION OF RHOC AND KI67 IN CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL CARCINOMA TUTOR</b></a><br> <b>R. Yin</b><br> <em>West China Second University Hospital, Obstetrics and Gynecological Department, Chengdu, China</em><br> </p> <p> <b>130</b><br> <a href='PDF/621.pdf' target='_blank'><b>FOLLOW-UP OF LYMPHOEDEMA IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR CERVICAL CANCER</b></a><br> <b>M. Halaska</b>, M. Novackova, H. Robova, M. Pluta, R. Chmel, M. Charvat, L. Rob<br> <em>Charles University in Prague, Dept. of Obstetrics and Gynecology, Praha, Czech Republic</em><br> </p> <p> <b>131</b><br> <a href='PDF/631.pdf' target='_blank'><b>CONE BEAM CT BASED THREE-DIMENSIONAL PLANNING IN INTRACAVITARY BRACHYTHERAPY FOR CERVICAL CANCER</b></a><br> <b>L. Portelance</b><sup>1</sup>, H. Al-Halabi<sup>1</sup>, M. Duclos<sup>1</sup>, B. Reniers<sup>2</sup>, M. Bloemers<sup>1</sup>, T. Niazi<sup>3</sup>, B. Bahoric<sup>3</sup>, L. Souhami<sup>1</sup><br> <em><sup>1</sup>McGill University Health Center, Radiation Oncology, Montreal, Canada, <sup>2</sup>McGill University Health Center, Medical Physics, Montreal, Canada, <sup>3</sup>Jewish General Hospital, Radiation Oncology, Montreal, Canada</em><br> </p> <p> <b>132</b><br> <a href='PDF/669.pdf' target='_blank'><b>TAILORED MANAGEMENT OF IB2 STAGE CERVICAL CANCER</b></a><br> <b>D. Cibula</b>, J. Slama, D. Fischerova, D. Kuzel, M. Zikan, I. Pinkavova, P. Dundr, P. Freitag<br> <em>Charles University, Prague, Czech Republic</em><br> </p> <p> <b>133</b><br> <a href='PDF/681.pdf' target='_blank'><b> SENTINEL LYMPH NODE DETECTION IN PATIENTS WITH CERVICAL CANCER OF UTERUS </b></a><br> <b>B. Acharya</b><sup>1</sup>, J. Liu<sup>2</sup><br> <em><sup>1</sup>BPKMCH, Surgical Oncology, Bharatpur, Nepal, <sup>2</sup>Cancer Center, Sun Yat-sen University, Gynaecology Oncology, Guangzhou, China</em><br> </p> <p> <b>134</b><br> <a href='PDF/739.pdf' target='_blank'><b>5'-CPG ISLAND HYPERMETHYLATION OF FHIT GENE IN KOREAN CERVICAL CARCINOMAS</b></a><br> <b>K.-D. Ki</b><sup>1</sup>, S.-H. Park<sup>2</sup>, K.-T. Kim<sup>3</sup>, S.-Y. Tong<sup>1</sup>, J.-M. Lee<sup>1</sup>, S.-K. Lee<sup>1</sup><br> <em><sup>1</sup>East-West Neo Medical Center, Kyung Hee University, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of, <sup>2</sup>Kangnam Sacred Heart Hospital, Hallym University, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of, <sup>3</sup>Hanyang University Hospital, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>135</b><br> <a href='PDF/740.pdf' target='_blank'><b>SULFASALAZINE IN THE PREVENTION OF ACUTERADIATION ENTERITIS IN CANCER CERVIX PATIENTS RECEIVING CONCURRENT CHEMORADIATION</b></a><br> <b>J. Raju</b><br> <em>Health Care Global Enterprises (HCG), Radiation Oncology, Bangalore, India</em><br> </p> <p> <b>136</b><br> <a href='PDF/741.pdf' target='_blank'><b>IMMUNOGENICITY AND SAFETY OF GLAXOSMITHKLINE'S HPV-16/18 L1 VLP AS04 ADJUVANT VACCINE IN INDIAN FEMALES AGED 18-35 YEARS</b></a><br> <b>N. Bhatla</b><sup>1</sup>, V. Suri<sup>2</sup>, P. Basu<sup>3</sup>, S. Shastri<sup>4</sup>, S.K. Datta<sup>5</sup>, D. Bi<sup>5</sup>, D. Descamps<sup>5</sup>, H.L. Bock<sup>5</sup><br> <em><sup>1</sup>All India Institute of Medical Sciences, Dept. of Obstretics & Gynaecology, New Delhi, India, <sup>2</sup>Post-Graduate Institute of Medical Education & Research, Department of Obstetrics & Gynaecology, Chandigarh, India, <sup>3</sup>Chittaranjan National Cancer Institute, Dept. of Gynaecology & Oncology, Kolkata, India, <sup>4</sup>Tata Memorial Hospital, Dept. of Preventive Oncology, Mumbai, India, <sup>5</sup>GlaxoSmithKline Biologicals, Rixensart, Belgium</em><br> </p> <p> <b>137</b><br> <a href='PDF/745.pdf' target='_blank'>A REAL-TIME PCR BASED HIGH THROUGHPUT SCREENING SYSTEM FOR HIGH-RISK HPV DETECTION</a><br> <b>A. Sebe</b>, B. Szenthe, A. Kovács, M. Nyíri, C. Jeney, T. Takács<br> <em>GenoID Ltd., Budapest, Hungary</em><br> </p> <p> <b>138</b><br> <a href='PDF/785.pdf' target='_blank'><b>LAPAROSCOPIC SURGICAL STAGING FOR LOCALLY ADVANCED CERVICAL CANCER</b></a><br> <b>D.G. Hong</b>, I.S. Park, Y.L. Cho, Y.S. Lee<br> <em>Kyungpook National University, Daegu, Korea, Republic of</em><br> </p> <p> <b>139</b><br> <a href='PDF/804.pdf' target='_blank'><b>A PHASE II STUDY OF IRINOTECAN AND CISPLATINUM AS NEOADJUVANT TREATMENT IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER</b></a><br> <b>F. Raspagliesi</b><sup>1</sup>, A. Ditto<sup>2</sup>, L. Selvaggi<sup>3</sup>, L. Frigerio<sup>4</sup>, M. Melpignano<sup>5</sup>, S. Mancuso<sup>6</sup>, N. Donadello<sup>7</sup>, S. Tateo<sup>8</sup>, G. Giardina<sup>9</sup>, S. Pignata<sup>10</sup>, P. Scollo<sup>11</sup>, M. Marinaccio<sup>3</sup>, F. Zanaboni<sup>1</sup>, G. Scibilia<sup>11</sup>, G. Cormio<sup>3</sup>, M. Presti<sup>12</sup>, P. Benedetti-Panici<sup>13</sup><br> <em><sup>1</sup>National Cancer Institute, Gynecol Oncol, Milan, Italy, <sup>2</sup>National Cancer Institute, Milan, Italy, <sup>3</sup>Bari University, Obstetrics and Gynecology, Bari, Italy, <sup>4</sup>Maggiore Hospital, Obstetrics and Gynecology, Bergamo, Italy, <sup>5</sup>Azienda Ospedaliera di Cremona, Obstetrics and Gynecology, Cremona, Italy, <sup>6</sup>Policlinico Gemelli University, Obstetrics and Gynecology, Rome, Italy, <sup>7</sup>Insubria University, Obstetrics and Gynecology, Varese, Italy, <sup>8</sup>Fondazione Policlinico S. Matteo, Obstetrics and Gynecology, Pavia, Italy, <sup>9</sup>Turin University, Obstetrics and Gynecology, Turin, Italy, <sup>10</sup>Pascale Istituto Nazionale dei Tumori, Medical Oncology, Naples, Italy, <sup>11</sup>Cannizzaro Hospital, Obstetrics and Gynecology, Catania, Italy, <sup>12</sup>Voghera Hospital, Obstetrics and Gynecology, Voghera, Italy, <sup>13</sup>Sapienza University, Obstetrics and Gynecology, Rome, Italy</em><br> </p> <p> <b>140</b><br> <a href='PDF/813.pdf' target='_blank'><b>EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR 2± IN DIFFERENT PHASES AND IT´S ASSOCIATIVITY WITH CERVICAL CANCER</b></a><br> <b>Y. Shi</b>, Z. Peng<br> <em>West China Second Hospital of SiChuan University, Obstetrics and Gynecology, ChengDu, China</em><br> </p> <p> <b>141</b><br> <a href='PDF/828.pdf' target='_blank'><b>PREOPERATIVE PREDICTION OF THE LIKELIHOOD OF POSTOPERATIVE RADIOTHERAPY IN STAGE IB1 CERVICAL CANCER</b></a><br> I. Ruengkhachorn<sup>1</sup>, <b>K. Charoenkwan</b><sup>1</sup>, S. Khunamornpong<sup>2</sup>, J. Srisomboon<sup>1</sup><br> <em><sup>1</sup>Faculty of Medicine, Chiang Mai University, Department of Obstetrics and Gynecology, Chiang Mai, Thailand, <sup>2</sup>Faculty of Medicine, Chiang Mai University, Department of Pathology, Chiang Mai, Thailand</em><br> </p> <p> <b>142</b><br> <a href='PDF/829.pdf' target='_blank'><b>RELATIONSHIP BETWEEN LYMPHNODE METASTASIS AND HISTOPATHOLOGICAL PARAMETERS IN CARCINOMA CERVIX - A MULTIVARIENT ANALYSIS</b></a><br> <b>V.R. Pallavi</b>, U.C.D. Bafna, K. Umadevi<br> <em>Kidwai Memorial Institute of Oncology, Gynaec Oncology, Bangalore, India</em><br> </p> <p> <b>143</b><br> <a href='PDF/831.pdf' target='_blank'><b>PREVALENCE AND PREDICTING FACTORS OF PARAMETRIAL INVASION IN EARLY-STAGE CARCINOMA OF THE CERVIX</b></a><br> <b>K. Charoenkwan</b><sup>1</sup>, J. Srisomboon<sup>1</sup>, I. Ruengkhachorn<sup>1</sup>, S. Siriaunkgul<sup>2</sup>, S. Khunamornpong<sup>2</sup><br> <em><sup>1</sup>Faculty of Medicine, Chiang Mai University, Department of Obstetrics and Gynecology, Chiang Mai, Thailand, <sup>2</sup>Faculty of Medicine, Chiang Mai University, Department of Pathology, Chiang Mai, Thailand</em><br> </p> <p> <b>144</b><br> <a href='PDF/845.pdf' target='_blank'><b>PRESERVATION OF BLADDER FUNCTION AFTER NERVE-SPARING RADICAL HYSTERECTOMY IN CERVICAL CANCER PATIENTS </b></a><br> S.R. Lee, S.Y. Lee, W. Ju, <b>S.C. Kim</b><br> <em>Ewha Womans University, School of Medicine, Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>145</b><br> <a href='PDF/855.pdf' target='_blank'><b>PREDICTABILITY OF MAGNETIC RESONANCE SPECTROSCOPY CHOLINE PEAK IN THE OUTCOME OF WOMEN WITH CERVICAL CARCINOMA</b></a><br> <b>A. Garrett</b><sup>1</sup>, A. Dobrotwir<sup>2</sup>, T. Walsh<sup>1</sup>, D. Neesham<sup>3</sup><br> <em><sup>1</sup>King Edward Memorial Hospital, Gynaecologic Oncology, Perth, Australia, <sup>2</sup>Royal Women's Hospital for Women, Radiology, Melbourne, Australia, <sup>3</sup>Royal Women's Hospital for Women, Gynaecologic Oncology, Melbourne, Australia</em><br> </p> <p> <b>146</b><br> <a href='PDF/856.pdf' target='_blank'><b>PHASE II STUDY OF CONCURRENT CISPLATINUM WITH IFOSFAMIDE AND RADIOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CERVICAL CARCINOMA</b></a><br> <b>C. Leelaphatanadit</b><sup>1</sup>, S. Sangruchi<sup>2</sup>, C. Thirapakawong<sup>1</sup>, P. Inthasorn<sup>1</sup>, B. Viriyapak<sup>1</sup>, I. Suphanit<sup>1</sup><br> <em><sup>1</sup>Gyn. Oncologic Unit, Department of Obstetrics and Gynecology, Bangkok, Thailand, <sup>2</sup>Radiation Oncology Division, Faculty of Medicine, Siriraj Hospital Mahidol University, Department of Radiology, Bangkok, Thailand</em><br> </p> <p> <b>147</b><br> <a href='PDF/857.pdf' target='_blank'><b>DEFINING DETECTION THRESHOLD AND IMPROVING PROFICIENCY OF HPV TESTING IN CLINICAL SPECIMENS</b></a><br> <b>F.-Y. Chao</b><sup>1</sup>, A. Chao<sup>1</sup>, C.-C. Huang<sup>1</sup>, S. Hsueh<sup>2</sup>, J.-E. Yang<sup>1</sup>, S.-L. Huang<sup>1</sup>, L.-C. Wang<sup>1</sup>, M.-S. Jao<sup>1</sup>, H.-H. Chou<sup>1</sup>, C.-H. Lai<sup>1</sup><br> <em><sup>1</sup>Chang Gung Memorial Hosp, Dept. Obs&Gyn, Kueishan, Taoyuan, Taiwan, Republic of China, <sup>2</sup>Chang Gung Memorial Hosp, Dept. of Pathology, Kueishan, Taoyuan, Taiwan, Republic of China</em><br> </p> <p> <b>148</b><br> <a href='PDF/864.pdf' target='_blank'><b>THE OUTCOMES OF THE MANAGEMENT OF CONVENTIONAL SMERAS REVEALED ASC-US BY REPEATED CYTOLOGY USING LIQUID-BASED METHOD</b></a><br> <b>S. Chichareon</b><sup>1</sup>, K. Tungsinmunkong<sup>2</sup>, V. Wootipum<sup>1</sup>, R. Buha-Chat<sup>1</sup>, J. Hanprasertkul<sup>1</sup>, S. Tadsee<sup>1</sup><br> <em><sup>1</sup>Faculty of Medicine, Prince of Songkla University, Department of Obstetrics and Gynecology, Hat-Yai, Thailand, <sup>2</sup>Faculty of Medicine, Prince of Songkla University, Department of Pathology, Hat-Yai, Thailand</em><br> </p> <p> <b>149</b><br> <a href='PDF/866.pdf' target='_blank'><b>NERVE-SPARING SURGERY</b></a><br> <b>T. Kato</b><br> <em>National Cancer Center Hospital, Tokyo, Japan</em><br> </p> <p> <b>150</b><br> <a href='PDF/867.pdf' target='_blank'><b>PRE-TREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR CERVICAL CANCER</b></a><br> <b>H. Cho</b><sup>1</sup>, J.H. Kwon<sup>2</sup>, S.W. Kim<sup>2</sup>, S.H. Kim<sup>2</sup>, Y.T. Kim<sup>2</sup>, J.-H. Kim<sup>1</sup><br> <em><sup>1</sup>Yongdong Severance Hospital, Yonsei University College of Medicine, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of, <sup>2</sup>Severance Hospital, Yonsei University College of Medicine, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>151</b><br> <a href='PDF/869.pdf' target='_blank'><b>VISUAL INSPECTION OF CERVIX WITH ACETIC ACID (VIA): AS A SCREENING METHOD FOR CERVICAL NEOPLASIA IN LOW RESOURCE SETTING</b></a><br> <b>U. Singh</b>, H.P. Gupta, S. Mehrotra<br> <em>C.S.M. Medical University, Lucknow, India</em><br> </p> <p> <b>152</b><br> <a href='PDF/871.pdf' target='_blank'><b>CONCURRENT PARAMETRIAL BOOST DURING PELVIC RADIATION FOR LOCALLY ADVANCED CERVICAL CANCER. TOXICITY PROFILE AND APPLICABILITY IN LOW RESOURCE CENTRES</b></a><br> <b>U.N. Majeed</b>, M.A. Ilyas, M. Khalid, A. Jamshed, S. Hameed, M.A. Shah<br> <em>Shaukat Khanum Cancer Hospital and Research Center, Radiation Oncology, Lahore, Pakistan</em><br> </p> <p> <b>153</b><br> <a href='PDF/895.pdf' target='_blank'><b>EARLY STAGE CERVICAL CANCER WITH NEGATIVE PELVIC LYMPH NODES: PATTERN OF FAILURE AND COMPLICATION FOLLOWING RADICAL HYSTERECTOMY AND ADJUVANT RADIOTHERAPY</b></a><br> <b>K. Dave</b><br> <em>Gujarat Cancer & Research Institute, Gynaec-Oncology, Ahmedabad, India</em><br> </p> <p> <b>154</b><br> <a href='PDF/906.pdf' target='_blank'><b>EFFECT OF ANTI-INFLAMMATORY (IL-4, IL-10) CYTOKINE GENES IN RELATION TO RISK OF CERVIX CARCINOMA</b></a><br> M. Shekari<sup>1</sup>, R.C. Sobti<sup>1</sup>, <b>D.M. Kordi Tamandani</b><sup>2</sup>, V. Suri<sup>3</sup><br> <em><sup>1</sup>Panjab University, Department of Biotechnology, Chandigarh, India, <sup>2</sup>Punjab University, Department of Biotechnology, Chandigarh, India, <sup>3</sup>Post Graduate Institute of Medical Education and Research, Department of Obstetrics & Gynecology, Chandigarh, India</em><br> </p> <p> <b>155</b><br> <a href='PDF/909.pdf' target='_blank'><b>ECONOMIC <b>BURDEN OF LIFETIME TREATMENT COST AND QUALITY OF LIFE AMONG THAI CERVICAL CANCER PATIENTS</b><b>: PRELIMINARY REPORT</b></b></a><br> <b>S. Chichareon</b><sup>1</sup>, N. Leuwananonthachai<sup>2</sup>, R. Buha-Chat<sup>1</sup>, N. Praditsitthikorn<sup>3</sup><br> <em><sup>1</sup>Faculty of Medicine, Prince of Songkla University, Department of Obstetrics and Gynecology, Hat-Yai, Thailand, <sup>2</sup>Faculty of Medicine, Mahidol University, Department of Radiology, Bangkok, Thailand, <sup>3</sup>Health Intervention and Technology Assessment Program, Ministry of Public Health, Bangkok, Thailand</em><br> </p> <p> <b>156</b><br> <a href='PDF/912.pdf' target='_blank'><b>ADJUVANT CERVICECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX STAGE IB2-IIB POST CHEMORADIATION (PRELIMINARY REPORT)</b></a><br> <b>P. Inthasorn</b><sup>1</sup>, C. Thirapakawong<sup>1</sup>, S. Therasakvichaya<sup>1</sup>, M. Benjapibal<sup>1</sup>, C. Leelaphatanadit<sup>1</sup>, B. Viriyapak<sup>1</sup>, A. Jaishuen<sup>1</sup>, P. Pattaranutaporn<sup>2</sup><br> <em><sup>1</sup>Siriraj Hospital, Department of Obstetrics and Gynaecology, Bangkok, Thailand, <sup>2</sup>Faculty of Medicine Siriraj Hospital, Department of Radiation, Bangkok, Thailand</em><br> </p> <p> <b>157</b><br> <a href='PDF/920.pdf' target='_blank'><b>NOVEL MRI TECHNIQUES AS BIOMARKERS OF EARLY RESPONSE DETECTION IN ADVANCED CERVICAL CANCER</b></a><br> <b>V. Harry</b><sup>1</sup>, S. Semple<sup>2</sup>, F. Gilbert<sup>3</sup>, D. Parkin<sup>1</sup><br> <em><sup>1</sup>Aberdeen Royal Infirmary, Gynaecological Oncology, Aberdeen, United Kingdom, <sup>2</sup>Western General Hospital, Clinical Neurosciences, Edingburgh, United Kingdom, <sup>3</sup>University of Aberdeen, Radiology, Aberdeen, United Kingdom</em><br> </p> <p> <b>158</b><br> <a href='PDF/921.pdf' target='_blank'><b>PRELIMINARY RESULTS OF QUALITY OF LIFE IN THAI WOMEN DIAGNOSED CERVICAL CANCER AND CIN AT KING CHULALONGKORN MEMORIAL HOSPITAL</b></a><br> <b>S. Taneepanichskul</b><sup>1</sup>, S. Lertmaharit<sup>1</sup>, S. Pongpanich<sup>1</sup>, W. Termrungruanglert<sup>2</sup>, P. Havanond<sup>1</sup>, N. Khemapech<sup>2</sup>, C. Khorprasert<sup>2</sup>, O. Pattanaprateep<sup>3</sup><br> <em><sup>1</sup>College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand, <sup>2</sup>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, <sup>3</sup>MSD, Bangkok, Thailand</em><br> </p> <p> <b>159</b><br> <a href='PDF/923.pdf' target='_blank'><b>NEOADJUVANT CHEMORADIATION FOLLOWED BY RADICAL SURGERY IN PATIENTS WITH STAGE IIIB CERVICAL CANCER: FEASIBILITY, COMPLICATIONS AND CLINICAL OUTCOMES</b></a><br> F. Fanfani<sup>1</sup>, A. Fagotti<sup>1</sup>, G. Ferrandina<sup>2</sup>, M.C. Moruzzi<sup>1</sup>, F. Raspagliesi<sup>3</sup>, A. Ditto<sup>3</sup>, <b>G. Scambia</b><sup>1</sup><br> <em><sup>1</sup>Catholic University, Rome, Italy, <sup>2</sup>Catholic University, Campobasso, Italy, <sup>3</sup>National Cancer Institute, Milan, Italy</em><br> </p> <p> <b>160</b><br> <a href='PDF/938.pdf' target='_blank'><b>IS CLASS III NERVE-SPARING RADICAL HYSTERECTOMY A SAFE PROCEDURE? LONG-TERM RESULTS</b></a><br> <b>A. Ditto</b><sup>1</sup>, F. Martinelli<sup>2</sup>, F. Hanozet<sup>2</sup>, C. Reato<sup>3</sup>, E. Solima<sup>2</sup>, F. Zanaboni<sup>2</sup>, R. Fontanelli<sup>2</sup>, M.L. Carcangiu<sup>4</sup>, F. Raspagliesi<sup>1</sup><br> <em><sup>1</sup>National Cancer Institute, Gynecol Oncol, Milan, Italy, <sup>2</sup>National Cancer Institute, Milan, Italy, <sup>3</sup>Treviglio Hospital, Obstetrics and Gynecology, Treviglio, Italy, <sup>4</sup>National Cancer Institute, Department of Pathology, Milan, Italy</em><br> </p> <p> <b>161</b><br> <a href='PDF/940.pdf' target='_blank'><b>EVALUATION OF VISUAL INSPECTION WITH ACETIC ACID AND COLPOSCOPY FOR CERVICAL CANCER SCREENING IN WOMEN WITH SUSPECIOUS LOOKING CERVIX</b></a><br> <b>G. Durdi</b>, M.K. Swamy, K. Patil, A. Dalal, B. Sherigar<br> <em>Jawaharlal Nehru Medical College, Obstetrics & Gynaecology, Belgaum, India</em><br> </p> <p> <b>162</b><br> <a href='PDF/955.pdf' target='_blank'><b>CONSERVATIVE APPROACH WITH LAPAROSCOPIC PELVIC LYMPHADENECTOMY AND CONIZATION IN EARLY-STAGE CERVICAL CANCER PATIENTS</b></a><br> <b>F. Landoni</b>, M. Sideri, G. Parma, M. Peiretti, F. Sanguineti, M. Lucas, S. Boveri<br> <em>Istituto Europeo di Oncologia, Gynecology, Milan, Italy</em><br> </p> <p> <b>163</b><br> <a href='PDF/979.pdf' target='_blank'><b>ROLE OF SENTINEL LYMPH NODE BIOPSY IN EARLY CERVICAL CANCER-EARLY INDIAN EXPERIENCE</b></a><br> <b>S.P. Somashekhar</b><sup>1</sup>, R.V. Parameshwaran<sup>2</sup><br> <em><sup>1</sup>Manipal Comprehensive Cancer Center, Surgical & Gynec. Oncology, Bangalore, India, <sup>2</sup>Manipal Comprehensive Cancer Center, Manipal Hospital, Nuclear Medicine, Bangalore, India</em><br> </p> <p> <b>164</b><br> <a href='PDF/984.pdf' target='_blank'><b>CANCER OF THE CERVIX: A NEGLECTED HUMAN TRAGEDY IN DEVELOPING NATIONS</b></a><br> <b>A. Oguntayo</b><br> <em>Ahmadu Bello University Teaching Hospital, Zaria, Obstetric and Gynaecology, Zaria, Nigeria</em><br> </p> <p> <b>165</b><br> <a href='PDF/996.pdf' target='_blank'><b>MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN): REVIEW OF TREATMENT OPTIONS</b></a><br> <b>H.P. Gupta</b><br> <em>C.S.M. Medical University, Lucknow, India</em><br> </p> <p> <b>166</b><br> <a href='PDF/1005.pdf' target='_blank'><b>SURGICAL MANAGEMENT OF EARLY INVASIVE CERVICAL CANCER ASSOCIATED WITH PREGNANCY: REPORT OF TWO CASES</b></a><br> <b>R. Bhansali</b><br> <em>The Gujarat Cancer & Research Institute, Gynaec-Oncology, Ahmedabad, India</em><br> </p> <p> <b>167</b><br> <a href='PDF/1008.pdf' target='_blank'><b>ERCC1 C19007T POLYMORPHISM IS NOT ASSOCIATED WITH THE RISK AND INVASIVENESS OF CERVICAL CANER IN KOREAN WOMEN</b></a><br> <b>S.S. Han</b><sup>1</sup>, D.H. Kim<sup>1</sup>, N.H. Park<sup>2</sup>, Y.S. Song<sup>2</sup>, S.B. Kang<sup>2</sup>, J.W. Kim<sup>2</sup><br> <em><sup>1</sup>Chung-Ang University, Seoul, Korea, Republic of, <sup>2</sup>Seoul National University, Seoul, Korea, Republic of</em><br> </p> <p> <b>168</b><br> <a href='PDF/1017.pdf' target='_blank'><b>COLPOSCOPIC VISIBLE MARKS OF A CERVICAL HPV INFECTION</b></a><br> <b>J. Louwers</b><sup>1</sup>, M. Kocken<sup>1</sup>, J. Bijl, van der<sup>1</sup>, J. Berkhof<sup>2</sup>, P. Snijders<sup>3</sup>, C. Meijer<sup>3</sup>, R. Verheijen<sup>4</sup><br> <em><sup>1</sup>VU University Medical Center, Pathology / Gynaecology, Amsterdam, Netherlands, <sup>2</sup>VU University Medical Center, Clinical Epidemiology and Biostatistics, Amsterdam, Netherlands, <sup>3</sup>VU University Medical Center, Pathology, Amsterdam, Netherlands, <sup>4</sup>University Medical Center Utrecht, Gynaecology, Utrecht, Netherlands</em><br> </p> <p> <b>169</b><br> <a href='PDF/1066.pdf' target='_blank'><b>CLINICO-PATHOLOGY FEATURES OF 2078 CASES OFCERVICAL CANCER IN DR. CIPTOMANGUNKUSUMO HOSPITAL JAKARTA, INDONESIA</b></a><br> <b>H. Winarto</b><sup>1</sup>, A.D. Putra<sup>1</sup>, S. Purbadi<sup>1</sup>, A.P.M. Heinzt<sup>2</sup><br> <em><sup>1</sup>Faculty of Medicine, University of Indonesia, Dr. Ciptomangunkusumo Hospital, Gynecologic Oncology Division, Gynecology and Obstetrics Department, Jakarta, Indonesia, <sup>2</sup>The Dutch School of Gynecologic Oncology and Pelvic Surgery, Utrecht, Netherlands</em><br> </p> <p> <b>170</b><br> <a href='PDF/1073.pdf' target='_blank'><b>SALVAGE TREATMENT FOR CENTRAL PELVIC RECURRENCES FOR UTERINE CERVICAL CANCER</b></a><br> L. Hathout<sup>1</sup>, D. Provencher<sup>2</sup>, T.V. Nguyen<sup>1</sup>, <b>E.R. Sagr</b><sup>2</sup>, P. Drouin<sup>2</sup>, P. Gauthier<sup>2</sup>, M. Jolicoeur<sup>1</sup><br> <em><sup>1</sup>CHUM- Notre-Dame Hospital, Radiation Oncology, Montreal, Canada, <sup>2</sup>CHUM- Notre-Dame Hospital, Gynecology Oncology, Montreal, Canada</em><br> </p> <p> <b>171</b><br> <a href='PDF/1105.pdf' target='_blank'><b>A PPROSPECTIVE NONRANDOMIZED STUDY WITH NEOADJUVANT CHEMOTHERAPY IN BULKY IB/IIA CERVICAL CANCER</b></a><br> <b>R. Joshi</b><sup>1</sup>, L. Satyanarayana<sup>2</sup>, R.C. Joshi<sup>3</sup><br> <em><sup>1</sup>Dharamshila Cancer Hospital, Gynecologic Oncology, Delhi, India, <sup>2</sup>Institute of Cytology and Preventive Oncology, Health Research, Noida, India, <sup>3</sup>Northern Railway Central Hospital, Clinical Oncology, New Delhi, India</em><br> </p> <p> <b>172</b><br> <a href='PDF/1106.pdf' target='_blank'><b>THE EFFICACY AND TOXICITY OF NEADJUVANT CHEMOTHERAPY WITH CISPLATIN AND PACLITAXEL FOLLOWED BY RADICAL SURGERY IN LOCALLY ADVANCED CERVICAL CANCER</b></a><br> <b>A. Papadia</b><sup>1</sup>, S. Mammoliti<sup>2</sup>, K. Nishida<sup>1</sup>, E. Pacella<sup>3</sup>, J. Lucci<sup>1</sup>, N. Ragni<sup>3</sup><br> <em><sup>1</sup>University of Miami, Miller School of Medicine, Gynecologic Oncology, Miami, United States, <sup>2</sup>San Martino Hospital, Medical Oncology, Genova, Italy, <sup>3</sup>San Martino Hospital, University of Genova, Obstetrics and Gynecology, Genova, Italy</em><br> </p> <p> <b>173</b><br> <a href='PDF/1116.pdf' target='_blank'><b>TURKISH CONTRIBUTION TO THE GYNECOLOGIC ONCOLOGY LITERATURE BETWEEN 2000-2007</b></a><br> <b>P. Dursun</b><sup>1</sup>, M. Gultekin<sup>2</sup>, A. Ayhan<sup>1</sup><br> <em><sup>1</sup>Baskent University School of Medicine, Obstetrics and Gynecology, Ankara, Turkey, <sup>2</sup>Cankiri State Hospital, Obstetrics and Gynecology, Çankiri, Turkey</em><br> </p> <p> <b>174</b><br> <a href='PDF/1149.pdf' target='_blank'><b>VIRAL AND CELLULAR MARKERS IN HGSIL LESIONS</b></a><br> <b>G. Anton</b><sup>1</sup>, D. Socolov<sup>2</sup>, A.-C. Anton<sup>2</sup>, A. Botezatu<sup>3</sup>, F. Cornitescu<sup>4</sup>, S. Teleman<sup>2</sup>, M. Anton<sup>5</sup>, C. Bleotu<sup>3</sup>, C.-D. Goia<sup>3</sup><br> <em><sup>1</sup>Institute of Virology, Bucharest, Romania, <sup>2</sup>UMF, Lassy, Romania, <sup>3</sup>Institute of Virology: ' Stefan S. Nicolau', Bucharest, Romania, <sup>4</sup>UMF, Craiova, Romania, <sup>5</sup>UMF, Bucharest, Romania</em><br> </p> <p> <b>175</b><br> <a href='PDF/1150.pdf' target='_blank'><b>ROUTINE DOUBLE SMEARS AT FOLLOW UP POST COLPOSCOPY TREATMENT- AN UNECESSARY EXERCISE</b></a><br> <b>T.K. Madhuri</b><sup>1</sup>, S. Chachan<sup>2</sup>, A. Tailor<sup>1</sup>, S. Butler-Manuel<sup>1</sup><br> <em><sup>1</sup>Royal Surrey County Hospital, Department of Gynaeoncology, Guildford, United Kingdom, <sup>2</sup>Royal Surrey County Hospital, Department of Obstetrics & Gynaecology, Guildford, United Kingdom</em><br> </p> <p> <b>176</b><br> <a href='PDF/1151.pdf' target='_blank'><b>RELATIONSHIP BETWEEN SURGICAL-PATHOLOGIC RISK FACTORS AND STAGE IN EARLY STAGE CERVICAL CANCER </b></a><br> <b>S. Ozer</b>, T. Turan, B. Aykan Yildirim, U. Bozkurt, G. Tulunay, N. Boran, M.F. Kose, A. Haberal<br> <em>Etlik Maternity and Women's Health Teaching and Research Hospital, Oncology, Ankara, Turkey</em><br> </p> <p> <b>177</b><br> <a href='PDF/1155.pdf' target='_blank'><b>FACTORS DETERMINING LYMPH NODE INVOLVEMENT IN EARLY STAGE CERVICAL CANCER</b></a><br> <b>T. Turan</b>, B. Aykan Yildirim, U. Bozkurt, S. Ozer, G. Tulunay, N. Boran, M.F. Kose, A. Haberal<br> <em>Etlik Maternity and Women's Health Teaching and Research Hospital, Oncology, Ankara, Turkey</em><br> </p> <p> <b>178</b><br> <a href='PDF/1157.pdf' target='_blank'><b>SOLITARY HEPATIC METASTASIS OF A SQUAMOUS CELL CARCINOMA OF THE CERVIX: CASE REPORT AND REVIEW OF THE LITERATURE</b></a><br> <b>H. Haouari</b>, C. Van Pachterbeke<br> <em>Brugmann Hospital, Gynaecology-Obstetric, Bruxelles, Belgium</em><br> </p> <p> <b>179</b><br> <a href='PDF/1159.pdf' target='_blank'><b>FACTORS DETERMINING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN STAGE IB2 CERVICAL CANCER</b></a><br> <b>T. Turan</b>, B. Aykan Yildirim, G. Tulunay, N. Boran, S. Ozer, I. Kog, M.F. Kose, A. Haberal<br> <em>Etlik Maternity and Women's Health Teaching and Research Hospital, Oncology, Ankara, Turkey</em><br> </p> <p> <b>180</b><br> <a href='PDF/1188.pdf' target='_blank'><b>PREDICTION OF HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) USING MODIFIED REID INDEX</b></a><br> <b>D.G. Hong</b><sup>1</sup>, Y.S. Lee<sup>2</sup>, I.S. Park<sup>2</sup>, Y.L. Cho<sup>2</sup><br> <em><sup>1</sup>Kyungpook National University, Obstetrics and Gynecology, Daegu, Korea, Republic of, <sup>2</sup>Kyungpook National University, Daegu, Korea, Republic of</em><br> </p> <p> <b>181</b><br> <a href='PDF/1195.pdf' target='_blank'><b>PREVALENCE OF CERVICAL INTRA-EPITHELIAL NEOPLASIA IN A DEVELOPING NATION</b></a><br> <b>A. Oguntayo</b><sup>1</sup>, M. Samaila<sup>2</sup><br> <em><sup>1</sup>Ahmadu Bello University Teaching Hospital Zaria, Obstetric and Gynaecology, Zaria, Nigeria, <sup>2</sup>Ahmadu Bello University Teaching Hospital, Zaria, Pathology, Zaria, Nigeria</em><br> </p> <p> <b>182</b><br> <a href='PDF/1203.pdf' target='_blank'><b>EXPRESSION OF KI-67 IN LOW GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (LSIL) CERVICAL CYTOLOGY TO PREDICT HIGH GRADE LESIONS IN SUBSEQUENT HISTOPATHOLOGY </b></a><br> <b>S. Manusirivithaya</b><sup>1</sup>, S. Tangjitgamol<sup>1</sup>, S. Tanwanich<sup>2</sup>, S. Jesadapatarakul<sup>2</sup><br> <em><sup>1</sup>Bangkok Metropolitan Administration Medical College and Vajira Hospital, Obstetrics and Gynecology, Bangkok, Thailand, <sup>2</sup>Bangkok Metropolitan Administration Medical College and Vajira Hospital, Anatomical Pathology, Bangkok, Thailand</em><br> </p> <p> <b>183</b><br> <a href='PDF/1205.pdf' target='_blank'><b>RESIDUAL DISEASE IN ADJUVANT HYSTERECTOMY SPECIMENS AFTER CONCURRENT CHEMORADIATION IN PATIENTS WITH LOCALLY BULKY CERVICAL CANCER</b></a><br> <b>H. Werner</b><sup>1</sup>, R. Swenson<sup>2</sup>, H. Gray<sup>2</sup>, E. Swisher<sup>2</sup>, H. Tamimi<sup>2</sup>, B. Goff<sup>2</sup>, B. Greer<sup>2</sup>, W.-J. Koh<sup>3</sup><br> <em><sup>1</sup>RadiantCare Radiation Oncology, Lacey, United States, <sup>2</sup>University of Washington, Gynecologic Oncology, Seattle, United States, <sup>3</sup>University of Washington, Radiation Oncology, Seattle, United States</em><br> </p> <p> <b>184</b><br> <a href='PDF/1212.pdf' target='_blank'><b>STUDY OF THE DIAGNOSTIC EFFICACY OF  REAL TIME OPTICAL COHERENCE TOMOGRAPY AS AN ADJUNCT TO COLPOSCOPY FOR CERVICAL NEOPLASIA</b></a><br> <b>N. Wulan</b><sup>1</sup>, J. Belinson<sup>2</sup>, S. Belinson<sup>3</sup>, X. Rong<sup>1</sup>, Y. Zhu<sup>1</sup>, C. Wang<sup>1</sup>, B. Yang<sup>4</sup>, N. Tresser<sup>5</sup>, M. Mohr<sup>2</sup>, R. Wu<sup>1</sup><br> <em><sup>1</sup>Peking University Shenzhen Hospital, Obstetrics and Gynecology, Shenzhen, China, <sup>2</sup>Cleveland Clinic, Obstetrics and Gynecology, Cleveland, United States, <sup>3</sup>Northwestern University, Preventive Medicine, Chicago, United States, <sup>4</sup>Cleveland Clinic, Anatomic Pathology, Cleveland, United States, <sup>5</sup>Imalux Corporation, Cleveland, United States</em><br> </p> <p> <b>185</b><br> <a href='PDF/1218.pdf' target='_blank'><b>DEVELOPING AN INFORMATION DVD TO SUPPORT WOMEN UNDERGOING CHEMO-RADIOTHERAPY TREATMENT FOR CERVICAL CANCER. TOPIC: CERVICAL CANCER</b></a><br> <b>L. Webb</b><sup>1</sup>, A. Hocking<sup>2</sup>, K. Narayan<sup>3</sup><br> <em><sup>1</sup>Peter MacCallum Cancer Centre, Gynaecology Service, Melbourne, Australia, <sup>2</sup>Peter MacCallum Cancer Centre, Gynaecology, Medical Social Work, Melbourne, Australia, <sup>3</sup>Peter MacCallum Cancer Centre, Gynaecology, Radiation Oncology, Melbourne, Australia</em><br> </p> <p> <b>186</b><br> <a href='PDF/1222.pdf' target='_blank'><b>EFFICACY AND SAFETY OF CAPECITABINE (X) CHEMORADIOTHERAPY FOLLOWED BY ADJUVANT X IN LOCALLY ADVANCED CERVICAL CANCER (LACC): PHASE II RESULTS</b></a><br> <b>V. Lorvidhaya</b><sup>1</sup>, E. Domingo<sup>2</sup>, R. De los Reyes<sup>3</sup>, T. Sy Ortin<sup>4</sup>, P. Kamnerdsupaphon<sup>1</sup>, C. Lertbutsayanukul<sup>5</sup>, E. Vito-Cruz<sup>3</sup>, E. Taravichitkul<sup>1</sup>, N. Cupino<sup>2</sup>, P. Lertsanguansinchai<sup>5</sup><br> <em><sup>1</sup>Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, <sup>2</sup>Philippine General Hospital, University of the Philippines, Manila, Philippines, <sup>3</sup>Jose R Reyes Memorial Medical Center, Manila, Philippines, <sup>4</sup>Makati Medical Center, Makati, Philippines, <sup>5</sup>Chulalongkorn University, Bangkok, Thailand</em><br> </p> <p> <b>187</b><br> <a href='PDF/1225.pdf' target='_blank'><b>HPV TYPE-SPECIFIC PREVALENCE IN WOMEN, STRATIFIED BY LOCATION IN THE GENITAL TRACT (CERVIX, LOWER AND UPPER VAGINA, PERINEUM): IMPLICATIONS FOR SELF-SAMPLING </b></a><br> <b>J. Belinson</b><sup>1</sup>, H. Wang<sup>2</sup>, R. Pretorius<sup>3</sup>, J. Li<sup>2</sup>, J. Smith<sup>4</sup>, Y. Qiao<sup>2</sup><br> <em><sup>1</sup>Cleveland Clinic, Obstetrics and Gynecology, Cleveland, United States, <sup>2</sup>Cancer Institute Hospital of Beijing, Chinese Academy of Medical Sciences, Epidemiology, Beijing, China, <sup>3</sup>Kaiser Permanente, Obstetrics and Gynecology, Fontana, United States, <sup>4</sup>University of North Carolina, Epidemiology, Chapel Hill, United States</em><br> </p> <p> <b>188</b><br> <a href='PDF/1234.pdf' target='_blank'><b>IMMUNOGENICITY AND SAFETY OF CERVARIX<sup>TM</sup> IN HEALTHY WOMEN IN HONG KONG, SAR</b></a><br> <b>H. Ngan</b><sup>1</sup>, A.N.-Y. Cheung<sup>2</sup>, K.F. Tam<sup>3</sup>, K.K.-L. Chan<sup>3</sup>, H. Tang<sup>4</sup>, D. Bi<sup>4</sup>, D. Descamps<sup>4</sup>, H.L. Bock<sup>4</sup><br> <em><sup>1</sup>The University of Hong Kong, Department of Obstetrics and Gynaecology, Hong Kong, Hong Kong, <sup>2</sup>The University of Hong Kong, Department of Pathology, Hong Kong, China, <sup>3</sup>The University of Hong Kong, Department of Gynaecologic Oncology, Hong Kong, China, <sup>4</sup>GlaxoSmithKline Limited, GSK Biologicals, Rixensart, Belgium</em><br> </p> <p> <b>189</b><br> <a href='PDF/1236.pdf' target='_blank'><b>A COMPARISON BETWEEN LDR AND MRI CONFORMAL HDR BRACHYTHERAPY OF CERVICAL CANCER: RESULTS, PATTERNS OF FAILURE AND LATE COMPLICATIONS</b></a><br> K. Narayan<sup>1</sup>, <b>S. van Dyk</b><sup>2</sup>, R. Chrisanthi<sup>3</sup>, D. Bernshaw<sup>3</sup>, S. Kondalsamy-Chennakesavan<sup>4</sup><br> <em><sup>1</sup>Peter MacCallum Cancer Centre, Gynaecoly Oncology, Melbourne, Australia, <sup>2</sup>Peter MacCallum Cancer Centre, Radiation Therapy, Melbourne, Australia, <sup>3</sup>Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia, <sup>4</sup>Queensland Centre for Gynaecological Cancer, Brisbane, Australia</em><br> </p> <p> <b>190</b><br> <a href='PDF/1242.pdf' target='_blank'><b>A RETROSPECTIVE STUDY ON SCHAUTA- AMREICH IN A TERTIARY HOSPITAL</b></a><br> <b>M. Catabijan</b><br> <em>UP- PGH, Obstetrics and Gynecology- Section of Gynecologic Oncology, Manila City, Philippines</em><br> </p> <p> <b>191</b><br> <a href='PDF/1249.pdf' target='_blank'><b>COMPARISON OF TWO COLPOSCOPIC SCORING SYSTEMS</b></a><br> <b>A.P. Manjunath</b>, M. Vani<br> <em>Kasturba Medical College, Obstetrics & Gynecology, Manipal, India</em><br> </p> <p> <b>192</b><br> <a href='PDF/1250.pdf' target='_blank'><b>21 MONTHS EXPERIENCES; PRIMARY HPV SCREENING PILOT PROGRAM IN PROVINCE OF VOJVODINA (SERBIA)</b></a><br> <b>J. Rajovic</b><sup>1</sup>, L. Andrijevic<sup>2</sup>, M. Lucic<sup>3</sup>, D. Nincic<sup>1</sup>, A. Mandic<sup>1</sup>, A. Fenyvesi<sup>4</sup><br> <em><sup>1</sup>Oncology Institute of Vojvodina, Gynecology, Sremska Kamenica, Serbia, <sup>2</sup>Oncology Institute of Vojvodina, HPV Lab, Sremska Kamenica, Serbia, <sup>3</sup>Oncology Institute of Vojvodina, MRI Center, Sremska Kamenica, Serbia, <sup>4</sup>HC Senta, Pathology, Senta, Serbia</em><br> </p> <p> <b>193</b><br> <a href='PDF/1273.pdf' target='_blank'><b>COMPARISON BETWEEN COLPOSCOPICALLY DIRECTED BIOPSY AND LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE</b></a><br> W. Bunjongsilp, <b>S. Wilailak</b>, P. O-Prasertsawat<br> <em>Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Obstetrics-Gynecology, Bangkok, Thailand</em><br> </p> <p> <b>194</b><br> <a href='PDF/1295.pdf' target='_blank'><b>CERVICAL CANCER SURVIVAL AT THE AIN SHAMS GYNECOLOGICAL ONCOLOGY UNIT IN CAIRO</b></a><br> <b>A. El-Shalakany</b>, H. Khashaba, K. Kamal, S. Fayed, M. El-Hao<br> <em>Ain Shams University, Obstetrics & Gynecology - Gynecological Oncology Unit, Cairo, Egypt</em><br> </p> <p> <b>195</b><br> <a href='PDF/1296.pdf' target='_blank'><b>EXPERIENCE OF PAP SMEAR SCREENING AND HEALTH EDUCATION IN RURAL INDIA</b></a><br> <b>S. Girija</b><sup>1</sup>, A.P. Manjunath<sup>1</sup>, K.R. Sanjaykumar<sup>1</sup>, M.S. Vidyasagar<sup>2</sup><br> <em><sup>1</sup>Dr TMA Pai Rotary Hospital, Obstetrics & Gynecology, Karkala, India, <sup>2</sup>Kasturba Medical College, Radiotherapy and Oncology, Manipal, India</em><br> </p> <p> <b>196</b><br> <a href='PDF/1297.pdf' target='_blank'><b>RADICAL ABDOMINAL TRACHELECTOMY IN CERVICAL STUMP CANCER</b></a><br> R. Balacuit<sup>1</sup>, <b>J.T. Luna</b><sup>2</sup><br> <em><sup>1</sup>UP PGH Cancer Institute Gyne-Oncology, Ob/Gyn, Manila City, Philippines, <sup>2</sup>UP PGH OBGYN, Ob/Gyn, Manila, Philippines</em><br> </p> <p> <b>197</b><br> <a href='PDF/1302.pdf' target='_blank'><b>CUTANEOUS METASTASIS AT THE CALCANEAL AREA FROM CERVICAL CARCINOMA</b></a><br> <b>E. Badilla</b>, D. Benavides<br> <em>University of the Philippines - Philippine General Hospital, Section of Gynecologic Oncology - Department of Obstetrics and Gynecology, Manila, Philippines</em><br> </p> <p> <b>198</b><br> <a href='PDF/1306.pdf' target='_blank'><b>PELVIC EXENTERATION FOR RECURRENT GYNECOLOGIC MALIGNANCY: 22-YEAR EXPERIENCE AT RAJAVITHI'S HOSPITAL INTHAILAND </b></a><br> T. Assawathan, <b>W. Supakarapongkul</b>, S. Sornsukolrat, S. Tuipae, N. Prueksaritanond, S. Thitisagulwong, C. Vipupinyo<br> <em>Rajavithi's Hospital, Obstetrics and Gynecology, Bangkok, Thailand</em><br> </p> <p> <b>199</b><br> <a href='PDF/1325.pdf' target='_blank'><b>LIQUID-BASED CERVICAL CYTOLOGY IN COMPARISON TO CONVENTIONAL PAPANICOLAOU SMEAR: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL CONTROLLED TRIAL </b></a><br> S. Tangjitgamol<sup>1</sup>, S. Manusirivithaya<sup>2</sup>, <b>S. Jesadapatarakul</b><sup>3</sup>, S. Nguansangiam<sup>3</sup><br> <em><sup>1</sup>Bangkok Metropolitan Administration Medical College and Vajira Hospital, Obstetrics and Gynecology, Anatomical Pathology, Bangkok, Thailand, <sup>2</sup>Bangkok Metropolitan Administration Medical College and Vajira Hospital, Obstetrics and Gynecology, Bangkok, Thailand, <sup>3</sup>Bangkok Metropolitan Administration Medical College and Vajira Hospital, Anatomical Pathology, Bangkok, Thailand</em><br> </p> <p> <b>200</b><br> <a href='PDF/1331.pdf' target='_blank'><b>VIRAL AND CELLULAR MARKERS OF CERVICAL LESIONS PERSISTENCE</b></a><br> <b>A. Stanescu</b><sup>1</sup>, E. Nistor<sup>1</sup>, C. Bleotu<sup>2</sup>, A. Plesa<sup>2</sup>, A. Botezatu<sup>2</sup>, G. Anton<sup>2</sup><br> <em><sup>1</sup>Bucur Maternity, Bucharest, Romania, <sup>2</sup>Virusology Institut 'St. Nicolau', Bucharest, Romania</em><br> </p> <p> <b>201</b><br> <a href='PDF/1349.pdf' target='_blank'><b>CHEMOPREVENTIONIN CERVIX CANCER: MYTHS OR REAL POSSIBILITY IN THE ERA OF HPV VACCINES?</b></a><br> <b>M. Klimek</b><sup>1</sup>, K. Urbanski<sup>2</sup><br> <em><sup>1</sup>Institute of Oncology, Gynecology Oncology, Krakow, Poland, <sup>2</sup>Institute of Oncology, Gynecology Department, Krakow, Poland</em><br> </p> <p> <b>202</b><br> <a href='PDF/1372.pdf' target='_blank'><b>THE SYMPTOM EXPERIENCE AND SELF CARE IN THAI WOMEN WITH CERVICAL CANCER RECEIVING TREATMENT</b></a><br> <b>B. Sumdaengrit</b><sup>1</sup>, S. Hanucharurnkul<sup>1</sup>, M. Dodd<sup>2</sup>, W. Sarikapan<sup>3</sup>, K. Pongthavornkamol<sup>4</sup>, T. Vorapongsathorn<sup>5</sup><br> <em><sup>1</sup>Mahidol University, Nursing, Rachatevee, Thailand, <sup>2</sup>University of California at San Francisco, Physiology Nursing, San Francisco, United States, <sup>3</sup>Mahidol University, Ob-Gyn, Rachatevee, Thailand, <sup>4</sup>Mahidol University, Medical Surgical Nursing, Rachatevee, Thailand, <sup>5</sup>Mahidol University, Biostatistic, Rachatevee, Thailand</em><br> </p> <p> <b>203</b><br> <a href='PDF/1375.pdf' target='_blank'><b>MANAGEMENT OF ADENOCARCINOMA OF THE UTERINE CERVIX - A THERAPEUTIC CHALLENGE </b></a><br> <b>U.K. Devi</b><sup>1</sup>, U.D. Bafna<sup>1</sup>, C. Ramesh<sup>2</sup><br> <em><sup>1</sup>Kidwai Memorial Institute of Oncology, Gynaecological Oncology, Bangalore, India, <sup>2</sup>Kidwai Memorial Institute of Oncology, Epidemiology & Biostastics, Hospital Cancer Registry, Bangalore, India</em><br> </p> <p> <b>204</b><br> <a href='PDF/1402.pdf' target='_blank'><b>FERTILITY PRESERVATION IS NOW A REALISTIC OPTION FOR EARLY STAGE CERVICAL CANCER</b></a><br> <b>J. Shepherd</b>, A. Tozer, T. Ind<br> <em>St Bartholomew's Hospital, Gynaecological Oncology, London, United Kingdom</em><br> </p> <p> <b>205</b><br> <a href='PDF/1413.pdf' target='_blank'><b>PROTEOME ANALYSIS OF CERVICAL CARCINOMA</b></a><br> <b>M. Lomnytska</b><sup>1</sup>, S. Becker<sup>2</sup>, K. Hellman<sup>3</sup>, A.-C. Hellström<sup>3</sup>, N. Volodko<sup>4</sup>, L. Prymak<sup>5</sup>, S. Struk<sup>5</sup>, U. Hellman<sup>6</sup>, S. Souchelnytskyi<sup>2</sup>, M. Mints<sup>7</sup>, S. Andersson<sup>7</sup>, G. Auer<sup>2</sup><br> <em><sup>1</sup>Lviv National Medical University, Department of Oncology and Medical Radiology, Lviv, Ukraine, Karolinska University Hospital-Huddinge, Karolinska Institutet, Division of Obstetrics and Gynecology, Department for Clinical Science, Intervention and Technology, Stockholm, Sweden, <sup>2</sup>Karolinska University Hospital Solna, CCK, Department of Oncology-Pathology, Stockholm, Sweden, <sup>3</sup>Karolinska University Hospital, Karolinska Institute, Department of Gynecologic Oncology, Radiumhemmet, Stockholm, Sweden, <sup>4</sup>Lviv National Medical University, Department of Oncology and Medical Radiology, Lviv, Ukraine, <sup>5</sup>Lviv Regional Oncology Center, Department of the Pathology of Cervix, Lviv, Ukraine, <sup>6</sup>Ludwig Institute for Cancer Research, Uppsala, Sweden, <sup>7</sup>Karolinska University Hospital-Huddinge, Karolinska Institutet, Division of Obstetrics and Gynecology, Department for Clinical Science, Intervention and Technology, Stockholm, Sweden</em><br> </p> <p> <b>206</b><br> <a href='PDF/1417.pdf' target='_blank'><b>IMRT VS 3DCRT IN WOMEN WITH HIGH STAGE GYNAECOLOGIC CANCER</b></a><br> <b>A. Micheli</b>, A. Savarese, V. Landoni, G. Arcangeli<br> <em>Istituto Regina Elena, Roma, Italy</em><br> </p> <p> <b>207</b><br> <a href='PDF/1428.pdf' target='_blank'><b>LYMPH VASCULAR SPACE INVASION AND TUMOR SIZE AS PREDICTIVE FACTORS OF LYMPH NODAL METASTASES IN CERVICAL CANCER</b></a><br> <b>L. Mouková</b><sup>1</sup>, R. Feranec<sup>1</sup>, R. Nenutil<sup>2</sup>, E. Krej í<sup>2</sup>, E. L~i aYová<sup>2</sup>, I. Zichová<sup>2</sup>, P. Fabian<sup>2</sup>, L. `tefániková<sup>1</sup>, M. Bláha<sup>1</sup><br> <em><sup>1</sup>Masaryk Memorial Cancer Institute, Department of Gynaecological Oncology, Brno, Czech Republic, <sup>2</sup>Masaryk Memorial Cancer Institute, Department of Oncological and Experimental Pathology, Brno, Czech Republic</em><br> </p> <p> <b>208</b><br> <a href='PDF/1434.pdf' target='_blank'><b>A CROSS-SECTIONAL STUDY OF HPV INFECTION IN THE WOMEN OF TIBET AUTONOMOUS REGION OF CHINA</b></a><br> <b>K. Shen</b><sup>1</sup>, Q. Jin<sup>1</sup>, X.-R. Zhou<sup>2</sup>, H.-F. Huang<sup>1</sup>, J.-H. Leng<sup>1</sup>, W.-H. Zhang<sup>3</sup>, X.-M. Gong<sup>1</sup>, J.-H. Lang<sup>1</sup>, Y.-C. Zhu<sup>4</sup>, T. Lou<sup>5</sup>, X. Zhang<sup>6</sup>, B. Xiang<sup>7</sup>, P. Wang<sup>4</sup>, W.-X. Mo<sup>4</sup><br> <em><sup>1</sup>Peking Union Medical College Hospital, Department of Obstetrics and Gynecology, Beijing, China, <sup>2</sup>OB/GYN Hospital Fudan University Shanghai, Pathology, Shanghai, China, <sup>3</sup>Tumor Hospital Chinese Academy of Medical Sciences, Gynecological Oncology, Beijing, China, <sup>4</sup>Chinese Women Association, Chinese Women Development Foundation, Beijing, China, <sup>5</sup>Beijing TCT Medical Technology Co Ltd, Product development, Beijing, China, <sup>6</sup>China Kapu Hybribio Ltd, research department, chaozhou, China, <sup>7</sup>Beijing TCT Medical Technology Co Ltd, Product Development, Beijing, China</em><br> </p> <p> <b>209</b><br> <a href='PDF/1439.pdf' target='_blank'><b>CHEMOSENSITIVE AGENTS BY 3-DIMENSIONAL HISTOCULTURE DRUG RESPONSE ASSAY (HDRA) PROLONGS SURVIVAL IN ADVANCED CERVICAL CANCER PATIENTS, 3-YEAR FOLLOW-UP</b></a><br> Y.-H. Park<sup>1</sup>, <b>H.-B. Kim</b><sup>2</sup><br> <em><sup>1</sup>Hallym University Sacred Heart Hospital, Obstetrics and Gynecology, Anyang, Korea, Republic of, <sup>2</sup>Gangnam Sacred Hart Hospital, Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>210</b><br> <a href='PDF/1442.pdf' target='_blank'><b>SCREENING, PREVENTION AND TREATMENT IN LOW-RESOURCE SETTINGS</b></a><br> <b>N. Mbatani</b><br> <em>University of Cape Town, Obstetrics & Gynaecology, Cape Town, South Africa</em><br> </p> <p> <b>211</b><br> <a href='PDF/1454.pdf' target='_blank'><b>INTENSITY-MODULATED RADIATION THERAPY (IMRT) REDUCES SMALL BOWEL, RECTUM, AND BLADDER DOSES IN PATIENTS WITH CERVICAL CANCERS RECEIVING PELVIC IRRADIATION</b></a><br> <b>P.N. Patel</b>, R.K. Vyas, D.C. Bhavsar<br> <em>Gujarat Cancer & Research Institute, Department of Radiation Oncology, Ahmedabad, India</em><br> </p> <p> <b>212</b><br> <a href='PDF/1457.pdf' target='_blank'><b>THE CORRELATION OF HUMAN PAPILLOMA VIRUS E6/7 MRNA DETECTION WITH COLPOSCOPY AND HISTOLOGY IN HIV INFECTED PATIENTS WITH LSIL ON CYTOLOGY</b></a><br> <b>E. Hugo</b><sup>1</sup>, H. Van der Merwe<sup>1</sup>, H. Botha<sup>1</sup>, G. Smit<sup>2</sup>, M. Jansen van Vuuren<sup>2</sup><br> <em><sup>1</sup>University of Stellenbosch, Gynecological Oncology, Cape Town, South Africa, <sup>2</sup>University of Stellenbosch, Virology, Cape Town, South Africa</em><br> </p> <p> <b>213</b><br> <a href='PDF/1471.pdf' target='_blank'><b>RADICAL ABDOMINAL HYSTRECTOMY: TATA MEMORIAL HOSPITAL EXPERIENCE</b></a><br> <b>H. Tongaonkar</b>, R. Kerkar, A. Maheshwari, P. Nyati<br> <em>Tata Memorial Hospital, Uro-Gynaecology, Mumbai, India</em><br> </p> <p> <b>214</b><br> <a href='PDF/1473.pdf' target='_blank'><b>ACCEPTABILITY OF VISUAL INSPECTION TECHNIQUES FOR DETECTION OF CERVICAL PREMALIGNANT LESION</b></a><br> <b>E. Aladekomo</b>, O. Ajenifuja<br> <em>Gynae Oncology Oauthc, Obstetrics and Gynaecology, Ile-Ife, Nigeria</em><br> </p> <p> <b>215</b><br> <a href='PDF/1476.pdf' target='_blank'><b>NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN AND TAXOL FOLLOWED BY PELVIC NODE DISSECTION AND RADICAL HYSTERECTOMY IN LOCALLY ADVANCED CARCINOMA OF CERVIX</b></a><br> <b>P. Inthasorn</b>, C. Thirapakawong, M. Benjapibal, C. Leelaphatanadit, B. Viriyapak, A. Jaishuen, P. Chaopothong<br> <em>Faculty of Medicine Siriraj Hospital, Division of Gynaecologic Oncology, Department of Obsterics and Gynaecology, Bangkok, Thailand</em><br> </p> <p> <b>216</b><br> <a href='PDF/1485.pdf' target='_blank'><b>VALIDATION OF EXISTING PROGNOSTIC MODELS IN PATIENTS WITH EARLY STAGE CERVICAL CANCER</b></a><br> <b>P. Biewenga</b>, J. van der Velden, B.W.J. Mol, L.J. Stalpers, M.S. Schilthuis, M.R. Buist<br> <em>Academic Medical Center, Amsterdam, Netherlands</em><br> </p> <p> <b>217</b><br> <a href='PDF/1487.pdf' target='_blank'><b>A STUDY OF DISEASE FREE INTERVAL IN RELATION TO SURGICO-PATHOLOGICAL PROGNOSTICATORS IN PATIENTS WITH STAGE 1B SQUAMOUS CELL CERVICAL CARCINOMA</b></a><br> K. Uma Devi<sup>1</sup>, U.D. Bafna<sup>1</sup>, <b>N. Siva Sathya Dharma</b><sup>2</sup>, S. Saraswathi<sup>1</sup>, V.R. Pallavi<sup>1</sup>, S. Shanthala<sup>1</sup><br> <em><sup>1</sup>KMIO, Bangalore, India, <sup>2</sup>Kidwai Memorial Institute of Oncology, Department of Gynae Oncology, Bangalore, India</em><br> </p> <p> <b>218</b><br> <a href='PDF/1490.pdf' target='_blank'><b>PROGNOSTIC IMPACT OF SATELLITE-LYMPHOVASCULAR SPACE INVOLVEMENT IN EARLY-STAGE CERVICAL CANCER</b></a><br> <b>C. Kurzeder</b><sup>1</sup>, D. Herr<sup>1</sup>, V. Heilmann<sup>2</sup>, J. König<sup>3</sup>, K. Koretz<sup>2</sup>, R. Kreienberg<sup>2</sup><br> <em><sup>1</sup>University of Ulm Medical School, Department of Obstetrics and Gynecology, Ulm, Germany, <sup>2</sup>University of Ulm Medical School, Ulm, Germany, <sup>3</sup>Institute for Medical Biostatistics, Epidemiology and Informatics, Mainz, Germany</em><br> </p> <p> <b>219</b><br> <a href='PDF/1491.pdf' target='_blank'><b>NEW LASER TECHNOLOGIES AS UNIVERSAL SENSITIZERS FOR LOCALLY ADVANCED AND RECURRENT GYNECOLOGICAL CANCER RADIOTHERAPY</b></a><br> V. Titova<sup>1</sup>, N. Kharchenko<sup>2</sup>, J. Kreynina<sup>1</sup>, <b>L. Shevchenko</b><sup>1</sup>, V. Petrovsky<sup>1</sup>, A. Shipilova<sup>1</sup><br> <em><sup>1</sup>Russian Scientific Centre of Roentgenoradiology, Moscow, Russian Federation, <sup>2</sup>Russian University of People Friendship, Moscow, Russian Federation</em><br> </p> <p> <b>220</b><br> <a href='PDF/1496.pdf' target='_blank'><b>PROTECTIVE ROLE OF AMIFOSTINE DURING FRACTIONATED RADIOTHERAPY IN PATIENTS WITH CERVICAL CARCINOMA</b></a><br> <b>M. Mehta</b><sup>1</sup>, R. Vyas<sup>2</sup>, U. Suryanarayan<sup>2</sup>, D. Bhavsar<sup>2</sup>, P. Nandwani Patel<sup>2</sup><br> <em><sup>1</sup>The Gujarat Cancer & Research Institute, Department of Radiotherapy, Ahmedabad, India, <sup>2</sup>The Gujarat Cancer & Research Institute, 54, Radiotherapy Department, The Gujarat Cancer & Research Institute, New Civil Hospital Campus, Asarwa, Ahmedabad, India</em><br> </p> <p> <b>221</b><br> <a href='PDF/1511.pdf' target='_blank'><b>CONCURRENT CHEMORADIATION IN CARCINOMA CERVIX - AN M.C.S EXPERIENCE</b></a><br> <b>P. Singh</b>, V. Trivedi, J.K. Singh<br> <em>Mahavir Cancer Sansthan, Radiation Oncology, Patna, India</em><br> </p> <p> <b>222</b><br> <a href='PDF/1522.pdf' target='_blank'><b>KNOWLEDGE ON AND ATTITUDE TOWARD HUMAN PAPILLOMAVIRUS INFECTION AND ITS VACCINEIN A TURKISH SUBPOPULATION</b></a><br> <b>A. Onan</b><sup>1</sup>, S. Ozkan<sup>2</sup>, U. Korucuoglu<sup>1</sup>, N. Aksakal<sup>2</sup>, C. Taskiran<sup>1</sup>, R. Aygun<sup>2</sup>, H. Guner<sup>1</sup><br> <em><sup>1</sup>Gazi University, Obstetrics and Gynecology, Ankara, Turkey, <sup>2</sup>Gazi University, Public Health, Ankara, Turkey</em><br> </p> <p> <b>223</b><br> <a href='PDF/1527.pdf' target='_blank'><b>PREVALANCE AND GENOTYPING OF HUMAN PAPILLOMAVIRUS (HPV) BY IN HOUSE AND REAL-TIME PCR IN PATIENTS WITH SEVERAL CERVICAL PATHOLOGIES</b></a><br> B. Dinc<sup>1</sup>, <b>A. Onan</b><sup>2</sup>, G. Bozdayi<sup>1</sup>, C. Taskiran<sup>2</sup>, S. Rota<sup>1</sup>, H. Guner<sup>2</sup><br> <em><sup>1</sup>Gazi University, Medical Microbiology, Ankara, Turkey, <sup>2</sup>Gazi University, Obstetrics and Gynecology, Ankara, Turkey</em><br> </p> <p> <b>224</b><br> <a href='PDF/1536.pdf' target='_blank'><b>HUMAN PAPILLOMA VIRUS POSITIVITY IN PATIENTS WITH ABNORMAL CERVICAL CYTOLOGY</b></a><br> <b>A. Onan</b><sup>1</sup>, A. Acar<sup>1</sup>, I. Fidan<sup>2</sup>, C. Taskiran<sup>1</sup>, S. Rota<sup>2</sup>, R. Gursoy<sup>1</sup>, H. Guner<sup>1</sup><br> <em><sup>1</sup>Gazi University, Obstetrics and Gynecology, Ankara, Turkey, <sup>2</sup>Gazi University, Medical Microbiology, Ankara, Turkey</em><br> </p> <p> <b>225</b><br> <a href='PDF/1555.pdf' target='_blank'><b>CUTANEOUS METASTASIS FROM THE CERVICAL CANCER AND REVIEW OF THE LITERATURE</b></a><br> A. Agrawal<sup>1</sup>, P. Chu<sup>1</sup>, A. You<sup>2</sup>, <b>P. Ghatage</b><sup>3</sup><br> <em><sup>1</sup>Tom Baker Cancer Centre, Calgary, Canada, <sup>2</sup>Department of Oncology and Anatomic Pathology, Calgary, Canada, <sup>3</sup>Tom Baker Cancer Centre, Department Of Gynecology, Calgary, Canada</em><br> </p> <p> <b>226</b><br> <a href='PDF/1557.pdf' target='_blank'><b>THE EFFICACY OF CONIZATION ALONE IN TREATMENT OF PATIENTS WITH STAGE IA1 MICROINVASIVE CERVICAL CARCINOMA</b></a><br> <b>S.W. Lee</b><sup>1</sup>, W.-S. Son<sup>2</sup>, H.-J. You<sup>3</sup>, D.-Y. Kim<sup>4</sup>, J.-H. Kim<sup>4</sup>, Y.-M. Kim<sup>1</sup>, Y.-T. Kim<sup>4</sup>, J.-H. Nam<sup>4</sup><br> <em><sup>1</sup>University of Ulsan, Asan Medical Center, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of, <sup>2</sup>KangNeung Asan Hospital, Department of Obstetrics and Gynecology, Kangneung, Korea, Republic of, <sup>3</sup>Ulsan University Hospital, Department of Obstetrics and Gynecology, Ulsan, Korea, Republic of, <sup>4</sup>University of Ulsan, Department of Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>227</b><br> <a href='PDF/1559.pdf' target='_blank'><b>NEO-ADJUVANT CHEMOTHERAPY PLUS TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY AND LYMPHADENECTOMY IN STAGE IB<sub>2</sub>-IIB CERVICAL CANCER: A PILOT STUDY</b></a><br> <b>E. Vizza</b><sup>1</sup>, G. Corrado<sup>1</sup>, A. Pellegrino<sup>2</sup>, E. Baiocco<sup>1</sup>, R. Fruscio<sup>3</sup>, D. Vitobello<sup>4</sup>, C. Mangioni<sup>3</sup>, C. Chen<sup>1</sup><br> <em><sup>1</sup>Regina Elena National Cancer Institute, Department of Surgery, Division of Gynecologic Oncology, Rome, Italy, <sup>2</sup>Alessandro Manzoni Hospital, Division of Obstetrics and Gynecology, Lecco, Italy, <sup>3</sup>University of Milan-Bicocca, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Milan, Italy, <sup>4</sup>Casa di Cura Abano Terme, Division of Obstetrics and Gynecology, Padova, Italy</em><br> </p> <p> <b>228</b><br> <a href='PDF/1566.pdf' target='_blank'><b>THE LYMPHATIC DRAINAGE OF THE UTERINE CERVIX:ANATOMY AND SURGICAL IMPLICATIONS</b></a><br> <b>E. Alfredo</b><sup>1</sup>, V. Delmas<sup>2</sup>, V. Iannone<sup>1</sup>, A. Fagotti<sup>3</sup>, F. Fanfani<sup>3</sup>, G. Corrado<sup>1</sup>, G. Ferrandina<sup>1</sup>, G. Scambia<sup>3</sup><br> <em><sup>1</sup>Catholic University, Department of Gynecology, Campobasso, Italy, <sup>2</sup>Université Paris, Institute of Anatomy, Paris, France, <sup>3</sup>Catholic University, Department of Gynecology, Rome, Italy</em><br> </p> <p> <b>229</b><br> <a href='PDF/1580.pdf' target='_blank'><b>PRACTICAL AND EFFECTIVE CERVICAL CANCER PREVENTION: SINGLE VISIT APPROACH USING VIA AND CRYOTHERAPY IN AFRICA AND ASIA</b></a><br> <b>K. Limpaphayom</b><sup>1</sup>, E. Lu<sup>2</sup>, H. Sanghvi<sup>2</sup>, W. Eamratsameekol<sup>3</sup><br> <em><sup>1</sup>Chulalongkorn University, Obstetrics and Gynecology Department, Bangkok, Thailand, <sup>2</sup>Jhpiego/Johns Hopkins University, Baltimore, United States, <sup>3</sup>Phanomphrai Hospital, Roi-et, Thailand</em><br> </p> <p> <b>230</b><br> <a href='PDF/1591.pdf' target='_blank'><b>ROLE OF THIN-PREP AND IMMUCYTOCHEMICAL DETECTION METHODS IN HPV INDUCTED NEOPLASTIC AND PRENEOPLASTIC LESSIONS</b></a><br> <b>N. Kiriakopoulos</b>, I. Aggos, C. Gavala, P. Akritopoulos, I. Kotsidas, K. Akritopoulou, E. Gavalas<br> <em>Ippocratio General Hospital, Department of Obstetrics and Gynecology, Kos, Greece</em><br> </p> <p> <b>231</b><br> <a href='PDF/1594.pdf' target='_blank'><b>THE PREVALANCE OF HUMAN PAPILLOMA VIRUS INFECTIONS IN TURKEY</b></a><br> H. Guner<sup>1</sup>, <b>A. Onan</b><sup>1</sup>, S. Tunc<sup>1</sup>, I. Fidan<sup>2</sup>, S. Rota<sup>2</sup>, C. Taskiran<sup>1</sup><br> <em><sup>1</sup>Gazi University, Obstetrics and Gynecology, Ankara, Turkey, <sup>2</sup>Gazi University, Medical Microbiology, Ankara, Turkey</em><br> </p> <p> <b>232</b><br> <a href='PDF/1600.pdf' target='_blank'><b>THE URETERAL STRICTURE COMPLICATION AFTER TREATMENT FOR CANCER OF THE UTERINE CERVIX ACCORDING TO TREATMENT MODALITY</b></a><br> <b>K. Chun</b><sup>1</sup>, Y.-M. Kim<sup>1</sup>, D.-Y. Kim<sup>2</sup>, J.-H. Kim<sup>2</sup>, Y.T. Kim<sup>1</sup>, J.E. Mok<sup>3</sup>, J.H. Nam<sup>1</sup><br> <em><sup>1</sup>University of Ulsan College of Medicine, Asan Medical Center, Obstetrics and Gynecology, Seoul, Korea, Republic of, <sup>2</sup>University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of, <sup>3</sup>University of Kwandong College of Medicine Cheil General Hospital & Women's Health Care Center, Obstetrics and Gynecology, Seoul, Korea, Republic of</em><br> </p> <p> <b>233</b><br> <a href='PDF/1617.pdf' target='_blank'><b>CONCURRENT CHEMO- RADIATION THERAPY COMBINED WITH HYPOFRACTIONATED HIGH DOSE RATE BRACHYTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER</b></a><br> <b>L. Portelance</b><sup>1</sup>, W. El-Sheshtawy<sup>1</sup>, L. Souhami<sup>1</sup>, M. Duclos<sup>1</sup>, B. Bahoric<sup>2</sup>, L. Gilbert<sup>3</sup>, G. Stanimir<sup>3</sup>, C. Legler<sup>4</sup>, J. Strugeon<sup>4</sup>, J. Arseneau<sup>5</sup><br> <em><sup>1</sup>McGill University Health Center, Radiation Oncology, Montreal, Canada, <sup>2</sup>Jewish General Hospital, Radiation Oncology, Montreal, Canada, <sup>3</sup>McGill University Health Center, Gyneco-Oncology, Montreal, Canada, <sup>4</sup>McGill University Health Center, Medical Oncology, Montreal, Canada, <sup>5</sup>McGill University Health Center, Pathology, Montreal, Canada</em><br> </p> <p> <b>234</b><br> <a href='PDF/1623.pdf' target='_blank'><b>ADVANCES IN COMBINED USE OF REAL-TIME ULTRASOUND AND MRI IN IMAGED GYNAECOLOGIC BRACHYTHERAPY</b></a><br> <b>D. Bernshaw</b>, S. VanDyk, K. Narayan<br> <em>Peter MacCallum Cancer Centre, Radiation Oncology, East Melbourne, Australia</em><br> </p> <p> <b>235</b><br> <a href='PDF/1624.pdf' target='_blank'><b>A NOVEL ROLE OF THROMBOSPONDIN-1 IN CERVICAL CARCINOGENESIS: INHIBIT STROMA REACTION BY INHIBITING ACTIVATED FIBROBLASTS FROM INVADING CANCER</b></a><br> M.-P. Wu<sup>1</sup>, M.-J. Young<sup>2</sup>, C.-C. Tzeng<sup>3</sup>, C.-R. Tzeng<sup>4</sup>, L.-W. Wu<sup>5</sup>, <b>C.-Y. Chou</b><sup>6</sup><br> <em><sup>1</sup>Chi Mei Foundation Hospital, Department of Obstetrics and Gynecology, Tainai, Taiwan, Republic of China, <sup>2</sup>Chi Mei Foundation Hospital, Tainai, Taiwan, Republic of China, <sup>3</sup>Chi Mei Foundation Hospital, Department of Pathology, Tainai, Taiwan, Republic of China, <sup>4</sup>College of Medicine, Taipei Medical University, Department of Obstetrics and Gynecology, Taipei, Taiwan, Republic of China, <sup>5</sup>College of Medicine, National Cheng Kung University, Institute of Clinical Medicine, Tainai, Taiwan, Republic of China, <sup>6</sup>College of Medicine, National Cheng Kung University, Department of Obstetrics and Gynecology, Tainai, Taiwan, Republic of China</em><br> </p> <p> <b>236</b><br> <a href='PDF/1626.pdf' target='_blank'><b>SCEENING FOR CERVCAL CANCER IN A PRIMARY HEALTH CARE CLINIC IN A SUB-URBAN AREA OF LAGOS:THE CHALLENGES </b></a><br> <b>R. Anorlu</b><sup>1</sup>, E. Soetan<sup>2</sup>, A. Banjo<sup>3</sup>, A. Onyewuenyi<sup>4</sup>, C. Mezzalira<sup>5</sup>, M. Salia<sup>2</sup>, A. Olaitan<sup>6</sup>, T. Famodimu<sup>2</sup>, B. Ige<sup>2</sup>, P. Agrawal<sup>6</sup><br> <em><sup>1</sup>College of Medicine, University of Lagos, Obstetrics and Gynaecology, Lagos, Nigeria, <sup>2</sup>St Kizito's Primary Healthcare Clinic-Lekki, Women's Health, Lekki-Lagos, Nigeria, <sup>3</sup>College of Medicine, University of Lagos, Dept of Morbid Anatomy, Lagos, Nigeria, <sup>4</sup>Institute of Child Health and Primary Healthcare, Lagos University Teaching Hospital, Lagos, Nigeria, <sup>5</sup>St Kizito's Primary Healthcare Clinic-Lekki, Obstetrics and Gynaecology, Lekki-Lagos, Nigeria, <sup>6</sup>The UCL & Elizabeth Garett Anderson Institute for Women's Health, Obstetrics and Gynaecology, London, United Kingdom</em><br> </p> <p> <b>237</b><br> <a href='PDF/1635.pdf' target='_blank'><b>HUMAN PAPILLOMAVIRUS INFECTION FOLLOWING RADIATION THERAPY OR CONCURRENT CHEMORADIATION FOR INVASIVE CERVICAL CANCER</b></a><br> <b>S. Intharaburan</b>, Y. Tanapat, K. Tatanan, K. Sangkhavasi, S. Komolpis, K. Buranawit<br> <em>Phramongkutklao Hospital, Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Bangkok, Thailand</em><br> </p> <p> <b>238</b><br> <a href='PDF/1656.pdf' target='_blank'><b>WORKING WITH CERVICAL PATIENTS IN GRIEF</b></a><br> <b>I. Athavia</b><br> <em>Cancer Patients Aid Association, Patient Care, Mumbai, India</em><br> </p> <p> <b>239</b><br> <a href='PDF/1682.pdf' target='_blank'><b>EXPRESSION OF PROANGIOGENIC FACTORS: VEGF, VEGF-C AND VEGFR-2 IN CIN AND CERVICAL CANCER IN PREGNANT AND NON-PREGNANT WOMEN</b></a><br> <b>R. Jach</b><sup>1</sup>, A. Basta<sup>1</sup>, J. Dulinska<sup>2</sup>, A. Szczudrawa<sup>1</sup>, P. Laidler<sup>2</sup><br> <em><sup>1</sup>Jagiellonian University, Medical College, Chair of Gynecology and Obstetrics, Department of Gynecology, Obstetrics and Oncology, Krakow, Poland, <sup>2</sup>Jagiellonian University, Medical College, Chair of Medical Biochemistry, Krakow, Poland</em><br> </p> <p> <b>240</b><br> <a href='PDF/1686.pdf' target='_blank'><b>POSTOPERATIVE MYOCARDIAL INFARCTION AMONG GYNECOLOGIC ONCOLOGY PATIENTS</b></a><br> <b>M.A. Clark</b><br> <em>First Dayton Gynecologic Oncology Clinic, Wright State University School of Medicine, Dept. Gynecologic Oncology, Dayton, United States</em><br> </p> <p> <b>241</b><br> <a href='PDF/1693.pdf' target='_blank'><b>COMBINED CHEMOTHERAPY (CT) WITH CISPLATIN PLUS PACLITAXEL AND RADIOTHERAPY (RT) IN ADVANCED CERVICAL CANCER (ACC) PATIENTS: EIGHT YEAR FOLLOW-UP OF A PHASE II STUDY</b></a><br> <b>M. Bruzzone</b>, L. Miglietta, P. Giglione, F. Giannelli, M.G. Centurioni, A. Puppo, P. Cristoforoni, M. Ferrarini<br> <em>Istituto Nazionale Ricerca sul Cancro, Genova, Italy</em><br> </p> <p> <b>242</b><br> <a href='PDF/1703.pdf' target='_blank'><b>PREVENTING CERVICAL CANCER: STAKEHOLDER ATTITUDES TOWARD <i>FASTHPV</i>-FOCUSED SCREENING PROGRAMS IN ROI-ET PROVINCE, THAILAND</b></a><br> L.A. Trope<sup>1</sup>, <b>B. Chumworthayi</b><sup>2</sup>, P.D. Blumenthal<sup>3</sup><br> <em><sup>1</sup>Stanford University, Program in Science, Technology and Society, Stanford, United States, <sup>2</sup>Khon Kaen University, Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen, Thailand, <sup>3</sup>Stanford University School of Medicine, Reproductive Health Services and Research, Stanford, United States</em><br> </p> <a href='index.asp'>Back</a><br> </td> </tr> <tr> <td colspan="2" ><img src="../images/bottom.gif" width="750" height="28"></td> </tr> <tr> <td colspan="2"><div id="botmenu"> <table width="100%" border="0" align="center" cellpadding="0" cellspacing="0" > <tr> <td width="75"><img src="http://www.kenes.com/aging/essam/images/trans.gif" width="152" height="8"></td> <td width="75"><a href="contact.asp">Contact </a></td> <td align="center"> &copy; IGCS-12, 2008. All Rights Reserved <a href="http://www.kenes.com/" target="_blank">KENES INTERNATIONAL</a></td> <td><img src="../images/trans.gif" width="20" height="8"><a href="site_map.asp">Site Map</a></td> </tr></table> </div><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-2239153-25"; urchinTracker(); </script></td> </tr> </table> </body> </html>